A 42 year old female patient is suffering from type 2 DM since 16 years and hypothyroidism since 23 years on medication on a regular checkup 1.thyroxine sodium 88 2.lumia 3.prolomet xl 25 4.pantacid 80 5.rosvastatin 10mg 6.sederom 7.dapagliflozin 10mg 8.zukanorm M1000 She has c/o decrease blood level since 3-4 months and generalised weakness, umbilical hernia,joint pains,weight loss, low BP below 95 mmhg, what is the actual causes for this and how to overcome diagnose it?
severe microcytic hypochromic anaemia iron deficiency diagnosis treatment in diabetes
SGLT2 inhibitor dapagliflozin hypotension volume depletion weight loss anaemia
metformin vitamin B12 deficiency anaemia macrocytic microcytic diabetes
| Test | Value | Status |
|---|---|---|
| Hb | 7.6 g/dL | π΄ Severely low (ref 12β15) |
| MCV | 60.7 fL | π΄ Severely microcytic (ref 83β101) |
| MCH | 16.8 pg | π΄ Hypochromic (ref 27β32) |
| MCHC | 27.7 g/dL | π΄ Low (ref 31.5β34.5) |
| HCT | 27.5% | π΄ Low (ref 36β46) |
| FBS | 173 mg/dL | π΄ Uncontrolled |
| PPBS | 268 mg/dL | π΄ Uncontrolled |
| HbA1c | 8.4% | π΄ Action required (>8.0) |
| TSH | 2.83 mIU/mL | β Within range on thyroxine |
| T3/T4 | Normal | β |
| Uric Acid | 1.9 mg/dL | π‘ Low (ref 2.6β6.0) |
| Globulin | 4.20 g/dL | π‘ High (ref 1.8β3.6) |
| A/G Ratio | 1.02 | π΄ Reversed (ref 1.2β2.2) |
| Lipid Profile | All within range | β |
| Creatinine | 1.0 mg/dL | β |
| RF (IgM) | Non-reactive | β |
| Parameter | Value | Target |
|---|---|---|
| FBS | 173 mg/dL | <130 |
| PPBS | 268 mg/dL | <180 |
| HbA1c | 8.4% | <7.0 (ADA) |
| Drug | Concern |
|---|---|
| Thyroxine | Iron and calcium must be taken 4 hours apart β iron chelates T4 |
| Metformin (Zukanorm) | B12 deficiency β supplement B12 |
| Dapagliflozin | Volume depletion + weight loss + BP lowering β contributes to hypotension in anaemic patient |
| Prolomet XL 25 | Beta-blocker blunts tachycardia response to anaemia β patient may not mount compensatory tachycardia |
| Pantacid 80 | High-dose PPI reduces iron absorption; check if 80 mg dose is necessary |
| Rosuvastatin 10 mg | Appropriate; no major concern |
| Sederom | Likely a nutritional supplement β identity unclear, verify content |
| Lumia | Drug identity unclear β verify; if vasodilator/antihypertensive, reassess given low BP |
| Symptom | Most Likely Cause(s) |
|---|---|
| Decreased blood level (anaemia) | Severe IDA (iron deficiency), likely from menorrhagia + chronic GI loss + malabsorption; B12 deficiency from metformin |
| Generalised weakness | Severe anaemia (Hb 7.6) + possible B12 deficiency + uncontrolled diabetes |
| Low BP <95 mmHg | Dapagliflozin (osmotic diuresis) + severe anaemia (vasodilation) + beta-blocker (Prolomet) blunting compensatory response |
| Weight loss | Dapagliflozin (glucosuria) + uncontrolled T2DM catabolism + anaemia-related anorexia |
| Joint pains | B12 deficiency neuropathy/arthralgia + diabetic musculoskeletal pain (RF negative, uric acid low) |
| Umbilical hernia | Likely pre-existing; weakness of abdominal wall from chronic illness |
β οΈ Clinical priority: The combination of Hb 7.6 + MCV 60.7 + symptomatic hypotension + weight loss requires urgent investigation for a source of chronic blood loss (GI/gynaecological) and prompt iron/B12 replacement. Occult malignancy must be excluded given the triad of weight loss + anaemia + reversed A/G ratio.
Also check this
| Parameter | Value | Reference | Status |
|---|---|---|---|
| Total Protein | 8.5 g/dL | 6.6β8.3 | π‘ Mildly high |
| Albumin | 4.3 g/dL | 3.2β4.6 | β Normal |
| Globulin | 4.20 g/dL | 1.8β3.6 | π΄ High |
| A/G Ratio | 1.02 | 1.2β2.2 | π΄ Reversed |
| Bilirubin Total | 0.3 mg/dL | 0.3β1.2 | β Normal |
| Bilirubin Direct | 0.1 mg/dL | <0.2 | β Normal |
| Bilirubin Indirect | 0.2 mg/dL | 0.1β1.0 | β Normal |
| SGOT | 12 U/L | <35 | β Normal |
| SGPT | 18 U/L | <35 | β Normal |
| Alkaline Phosphatase | 41 U/L | 30β120 | β Normal |
| GGT | Not reported | <38 | β |
| Condition | Why suspect | Test to order |
|---|---|---|
| Hepatitis B or C | Chronic viral hepatitis β elevated globulin even with normal transaminases in early/compensated phase | HBsAg, Anti-HCV |
| Tuberculosis | Weight loss + anaemia + weakness in South Asian patient | Chest X-ray, Mantoux/IGRA |
| Parasitic infection | Low uric acid, weight loss, tropical context | Stool microscopy, eosinophil count |
| Test | Reason |
|---|---|
| Serum Protein Electrophoresis (SPEP) | Elevated globulin β exclude myeloma/MGUS |
| HBsAg + Anti-HCV | Chronic hepatitis with normal transaminases |
| ANA + Anti-dsDNA | Autoimmune cause of elevated globulin + joint pains |
| CRP + ESR | Quantify inflammatory burden |
| Serum free light chains | If SPEP shows M-band |
| Chest X-ray | TB workup |
β οΈ SPEP (serum protein electrophoresis) is the single most important test to add at this stage to differentiate polyclonal (benign/inflammatory) from monoclonal (myeloma) gammopathy.
Complie the both information and provide one
| Parameter | Value | Reference | Status |
|---|---|---|---|
| Haemoglobin | 7.6 g/dL | 12.0β15.0 | π΄ Severely Low |
| RBC Count | 4.53 mil/cu.mm | 3.8β4.8 | β Normal |
| HCT (PCV) | 27.5% | 36β46 | π΄ Low |
| MCV | 60.7 fL | 83β101 | π΄ Severely Microcytic |
| MCH | 16.8 pg | 27β32 | π΄ Hypochromic |
| MCHC | 27.7 g/dL | 31.5β34.5 | π΄ Low |
| WBC | 7030 cell/cu.mm | 4000β10000 | β Normal |
| Platelets | 283000/ul | 150000β450000 | β Normal |
| Parameter | Value | Reference | Status |
|---|---|---|---|
| Fasting Blood Sugar | 173 mg/dL | 70β99 | π΄ High |
| Post Prandial | 268 mg/dL | 70β140 | π΄ High |
| HbA1c | 8.4% | <7.0 (target) | π΄ Action Required |
| Parameter | Value | Reference | Status |
|---|---|---|---|
| T3 Total | 1.24 ng/mL | 0.69β2.15 | β Normal |
| T4 Total | 99.2 ng/mL | 52β127 | β Normal |
| TSH | 2.83 uIU/mL | 0.30β4.5 | β Normal |
| Parameter | Value | Reference | Status |
|---|---|---|---|
| Total Protein | 8.5 g/dL | 6.6β8.3 | π‘ Mildly High |
| Albumin | 4.3 g/dL | 3.2β4.6 | β Normal |
| Globulin | 4.20 g/dL | 1.8β3.6 | π΄ High |
| A/G Ratio | 1.02 | 1.2β2.2 | π΄ Reversed |
| Bilirubin Total | 0.3 mg/dL | 0.3β1.2 | β Normal |
| SGOT | 12 U/L | <35 | β Normal |
| SGPT | 18 U/L | <35 | β Normal |
| Alkaline Phosphatase | 41 U/L | 30β120 | β Normal |
| Parameter | Value | Reference | Status |
|---|---|---|---|
| Total Cholesterol | 131 mg/dL | <200 | β Normal |
| Triglycerides | 82 mg/dL | <150 | β Normal |
| HDL | 47 mg/dL | >40 | β Normal |
| LDL | 67.60 mg/dL | <100 | β Normal |
| VLDL | 16.40 mg/dL | 6β38 | β Normal |
| CHOL/HDL Ratio | 2.79 | 3.5β5.0 | β Normal |
| LDL/HDL Ratio | 1.44 | 2.5β3.5 | β Normal |
| Parameter | Value | Reference | Status |
|---|---|---|---|
| Urea | 27 mg/dL | 17β43 | β Normal |
| Creatinine | 1.0 mg/dL | 0.8β1.30 | β Normal |
| Calcium | 8.9 mg/dL | 8.80β10.60 | β Normal |
| Uric Acid | 1.9 mg/dL | 2.6β6.0 | π‘ Low |
| Bilirubin Total | 0.3 mg/dL | 0.3β1.2 | β Normal |
| RF (IgM) | Non-reactive | <10 IU/mL | β Normal |
| Drug | Purpose | Concern |
|---|---|---|
| Thyroxine Sodium 88 mcg | Hypothyroidism | Must be taken 4 hrs before iron/calcium supplements |
| Lumia | Unclear β verify | If antihypertensive/vasodilator, reassess given BP <95 mmHg |
| Prolomet XL 25 (Metoprolol) | Beta-blocker (cardiac/BP) | Blunts compensatory tachycardia in severe anaemia; compounds hypotension |
| Pantacid 80 (Pantoprazole 80 mg) | GI protection | High dose reduces iron absorption; verify necessity of 80 mg |
| Rosuvastatin 10 mg | Dyslipidaemia | Safe β SGOT/SGPT completely normal |
| Sederom | Verify content | Likely nutritional supplement β confirm |
| Dapagliflozin 10 mg | T2DM (SGLT2i) | Osmotic diuresis β volume depletion β hypotension; causes weight loss; lowers uric acid |
| Zukanorm M1000 (Metformin 1000 mg) | T2DM | 16+ years use β Vitamin B12 deficiency (not yet checked) |
| Cause | Mechanism |
|---|---|
| Severe anaemia (Hb 7.6) | Reduced oxygen delivery to all tissues |
| Probable B12 deficiency | Neurological and muscular dysfunction |
| Uncontrolled T2DM (HbA1c 8.4%) | Muscle catabolism, chronic fatigue |
| Low BP | Reduced cerebral and tissue perfusion |
| Hypothyroid residual effect | Even on treatment, muscle weakness can persist |
| Cause | Mechanism |
|---|---|
| Dapagliflozin | Glucosuria = caloric loss via urine (1β3 kg expected) |
| Uncontrolled T2DM | Hyperglycaemia-driven fat and muscle catabolism |
| Severe anaemia | Reduced appetite, anorexia |
| β οΈ Occult malignancy | Must exclude β weight loss + anaemia + elevated globulin + reversed A/G ratio = red flag triad |
| Cause | Evidence |
|---|---|
| Probable B12 deficiency | Neuropathic arthralgia β not yet excluded |
| Diabetic musculoskeletal pain | 16-year T2DM |
| Anaemia-related myalgia | Tissue hypoxia β muscle aches |
| Rheumatoid Arthritis β Excluded | RF non-reactive |
| Gout β Excluded | Uric acid 1.9 (low, partly from dapagliflozin) |
| Seronegative arthritis | Anti-CCP not yet checked β cannot fully exclude |
| SLE/Autoimmune | ANA not checked β elevated globulin raises possibility |
| Diagnosis | Likelihood | Key Test |
|---|---|---|
| Chronic inflammation from T2DM | Most likely | CRP, ESR |
| Hepatitis B or C | Must exclude | HBsAg, Anti-HCV |
| Tuberculosis | Must exclude (weight loss + anaemia + South Asian) | CXR, IGRA |
| Multiple Myeloma / MGUS | Must exclude urgently | SPEP + Immunofixation |
| SLE / Autoimmune | Possible | ANA, anti-dsDNA |
β οΈ The combination of weight loss + severe anaemia + elevated globulin + reversed A/G ratio + joint pains + low uric acid constitutes a red flag cluster that mandates formal exclusion of haematological malignancy (multiple myeloma).
| Parameter | Current | Target (ADA) |
|---|---|---|
| FBS | 173 mg/dL | <130 mg/dL |
| PPBS | 268 mg/dL | <180 mg/dL |
| HbA1c | 8.4% | <7.0% |
| Test | Reason |
|---|---|
| Serum Ferritin + Serum Iron + TIBC | Confirm IDA severity |
| Peripheral Blood Smear | RBC morphology (pencil cells = IDA) |
| Serum Vitamin B12 + Folate | 16 years metformin β likely deficient |
| Reticulocyte Count | Bone marrow response to anaemia |
| Stool Occult Blood Test Γ3 | Exclude GI bleeding source |
| SPEP + Immunofixation | Elevated globulin β exclude myeloma |
| CRP + ESR | Quantify inflammation |
| Test | Reason |
|---|---|
| HBsAg + Anti-HCV | Chronic hepatitis (elevated globulin, weight loss) |
| Chest X-ray | TB screening (weight loss + anaemia) |
| ANA + Anti-dsDNA | SLE/autoimmune β joint pains + globulin |
| Anti-CCP antibody | Seronegative RA cannot be excluded by RF alone |
| Gynaecology referral + menstrual history | Menorrhagia as cause of IDA |
| Upper GI endoscopy | Chronic pantoprazole use + IDA β exclude peptic ulcer/gastritis |
| Fructosamine | True glycaemic control in setting of severe anaemia |
| Microalbuminuria + eGFR | 16-year T2DM β diabetic nephropathy screening |
| Test | Reason |
|---|---|
| TPO Antibody (if not done) | Autoimmune hypothyroid β risk of other autoimmune diseases |
| Interaction | Action |
|---|---|
| Iron β Thyroxine | 4-hour gap mandatory β iron drastically reduces T4 absorption |
| Dapagliflozin β Hypotension | Monitor BP; hold if systolic <90 mmHg |
| Metformin β B12 deficiency | Supplement B12 indefinitely while on metformin |
| Prolomet + Anaemia | Beta-blocker prevents compensatory tachycardia β monitor for syncope |
| Pantoprazole 80 mg β βIron absorption | Review dose necessity; consider stepping down to 40 mg |
| Rosuvastatin | Safe β liver enzymes completely normal |
| Problem | Cause | Action |
|---|---|---|
| Hb 7.6 β Severe Anaemia | IDA (menorrhagia/GI loss) + probable B12 deficiency | Iron + B12 supplements; investigate source |
| Weakness | Anaemia + B12 deficiency + uncontrolled DM + low BP | Treat all simultaneously |
| BP <95 mmHg | Dapagliflozin + Prolomet + severe anaemia (vasodilation) | Hydration; review dapagliflozin; reassess Prolomet |
| Weight loss | SGLT2i + uncontrolled DM + anaemia; exclude malignancy | SPEP; oncology alert |
| Joint pains | B12 deficiency + diabetic neuropathy; RF negative | B12 first; anti-CCP, ANA if persistent |
| Elevated Globulin | Chronic inflammation vs. myeloma vs. chronic infection | SPEP + HBsAg + Anti-HCV + CXR urgently |
| HbA1c 8.4% | Suboptimal glycaemic control | Add GLP-1 agonist; diabetologist referral |
| Umbilical Hernia | Pre-existing, worsened by weakness | Surgical referral after Hb correction |
| Thyroid | Well-controlled on Thyroxine 88 mcg | Continue; enforce iron-thyroxine timing |
β οΈ Most urgent action: Rule out multiple myeloma (SPEP) and identify the source of iron deficiency (GI endoscopy + gynaecology). These two investigations will define the entire further management pathway.This report is a clinical decision support document. All management decisions must be made by the treating physician with full clinical context.
Corrections: lumina vitamin D3 ,sederOM ferric di phosphate with vitamin c and vitamin B12 check composition and include in above
| Parameter | Value | Reference | Status |
|---|---|---|---|
| Haemoglobin | 7.6 g/dL | 12.0β15.0 | π΄ Severely Low |
| RBC Count | 4.53 mil/cu.mm | 3.8β4.8 | β Normal |
| HCT (PCV) | 27.5% | 36β46 | π΄ Low |
| MCV | 60.7 fL | 83β101 | π΄ Severely Microcytic |
| MCH | 16.8 pg | 27β32 | π΄ Hypochromic |
| MCHC | 27.7 g/dL | 31.5β34.5 | π΄ Low |
| WBC | 7030 cell/cu.mm | 4000β10000 | β Normal |
| Platelets | 283000/ul | 150000β450000 | β Normal |
| Parameter | Value | Reference | Status |
|---|---|---|---|
| Fasting Blood Sugar | 173 mg/dL | 70β99 | π΄ High |
| Post Prandial | 268 mg/dL | 70β140 | π΄ High |
| HbA1c | 8.4% | <7.0 (target) | π΄ Action Required |
| Parameter | Value | Reference | Status |
|---|---|---|---|
| T3 Total | 1.24 ng/mL | 0.69β2.15 | β Normal |
| T4 Total | 99.2 ng/mL | 52β127 | β Normal |
| TSH | 2.83 uIU/mL | 0.30β4.5 | β Normal |
| Parameter | Value | Reference | Status |
|---|---|---|---|
| Total Protein | 8.5 g/dL | 6.6β8.3 | π‘ Mildly High |
| Albumin | 4.3 g/dL | 3.2β4.6 | β Normal |
| Globulin | 4.20 g/dL | 1.8β3.6 | π΄ High |
| A/G Ratio | 1.02 | 1.2β2.2 | π΄ Reversed |
| Bilirubin Total | 0.3 mg/dL | 0.3β1.2 | β Normal |
| SGOT | 12 U/L | <35 | β Normal |
| SGPT | 18 U/L | <35 | β Normal |
| Alkaline Phosphatase | 41 U/L | 30β120 | β Normal |
| Parameter | Value | Reference | Status |
|---|---|---|---|
| Total Cholesterol | 131 mg/dL | <200 | β Normal |
| Triglycerides | 82 mg/dL | <150 | β Normal |
| HDL | 47 mg/dL | >40 | β Normal |
| LDL | 67.60 mg/dL | <100 | β Normal |
| VLDL | 16.40 mg/dL | 6β38 | β Normal |
| Parameter | Value | Reference | Status |
|---|---|---|---|
| Urea | 27 mg/dL | 17β43 | β Normal |
| Creatinine | 1.0 mg/dL | 0.8β1.30 | β Normal |
| Calcium | 8.9 mg/dL | 8.80β10.60 | β Normal |
| Uric Acid | 1.9 mg/dL | 2.6β6.0 | π‘ Low |
| RF (IgM) | Non-reactive | <10 IU/mL | β Normal |
| Drug | Correct Identity | Purpose | Clinical Relevance |
|---|---|---|---|
| Thyroxine Sodium 88 mcg | Levothyroxine | Hypothyroidism | Must be taken 4 hrs before iron/calcium |
| Lumina | Vitamin D3 supplement | Bone health / D3 deficiency | β οΈ Vitamin D3 level not checked β may be deficient despite supplementation |
| Prolomet XL 25 | Metoprolol Succinate (beta-blocker) | Cardiac / BP | Blunts tachycardia response to anaemia; compounds hypotension |
| Pantacid 80 | Pantoprazole 80 mg | GI protection | β οΈ High dose reduces iron absorption significantly |
| Rosuvastatin 10 mg | Statin | Dyslipidaemia | Safe β liver enzymes normal |
| Sederom | Ferric Diphosphate + Vitamin C + Vitamin B12 | Anaemia treatment | β οΈ Patient is ON iron + B12 yet Hb remains 7.6 β treatment-resistant anaemia requires urgent investigation |
| Dapagliflozin 10 mg | SGLT2 inhibitor | T2DM | Volume depletion β hypotension; glucosuria β weight loss; lowers uric acid |
| Zukanorm M1000 | Metformin 1000 mg | T2DM | Long-term use β B12 malabsorption (countered by Sederom) |
| Symptom | Primary Cause(s) | Contributing Cause(s) |
|---|---|---|
| Severe anaemia despite iron supplement | Active blood loss (menorrhagia/GI) + Pantoprazole blocking iron absorption | Vitamin D deficiency, chronic inflammation/hepcidin, diabetic EPO suppression |
| Generalised weakness | Hb 7.6 (tissue hypoxia) + Vitamin D deficiency | Low BP reducing perfusion, uncontrolled DM, hypothyroid residual |
| Low BP <95 mmHg | Dapagliflozin (osmotic diuresis) + severe anaemia (vasodilation) + Prolomet (blunted compensation) | Possible Lumina (Vitamin D3 has mild vasodilatory effect at high doses) |
| Weight loss | Dapagliflozin (glucosuria/caloric loss) + uncontrolled DM catabolism | Anaemia-related anorexia; β οΈ exclude malignancy |
| Joint pains | Vitamin D deficiency (osteomalacic arthralgia β now confirmed by Lumina prescription) + diabetic musculoskeletal pain | B12 neuropathy possible despite supplementation if absorption poor |
| Umbilical hernia | Pre-existing + worsened by muscle weakness (Vitamin D + anaemia) | Increased intra-abdominal pressure |
| Elevated Globulin / Reversed A/G | Chronic inflammatory state (T2DM) | Must exclude myeloma, hepatitis, TB |
| Low Uric Acid (1.9) | Dapagliflozin reduces uric acid by ~10% | |
| Uncontrolled DM (HbA1c 8.4%) | Inadequate glycaemic response to current regimen | HbA1c may be falsely lower due to severe anaemia |
| Test | Reason |
|---|---|
| Serum Ferritin + Serum Iron + TIBC | Confirm iron stores β is iron being absorbed at all? |
| Peripheral Blood Smear | Pencil cells, hypochromic cells, dimorphic picture |
| Reticulocyte Count | Is bone marrow responding to iron therapy? |
| Stool Occult Blood Test Γ3 | Active GI bleeding β explains failure of iron therapy |
| Serum 25-OH Vitamin D3 | Is Lumina achieving adequate Vitamin D levels? |
| SPEP + Immunofixation | Elevated globulin β urgently exclude multiple myeloma |
| CRP + ESR | Quantify hepcidin-driving inflammation |
| Test | Reason |
|---|---|
| Gynaecology referral + TVS | Menorrhagia, fibroids β primary source of blood loss |
| Upper GI Endoscopy | IDA not responding to supplements + chronic pantoprazole use |
| HBsAg + Anti-HCV | Elevated globulin, weight loss |
| Chest X-ray | TB (weight loss + anaemia + South Asian patient) |
| ANA + Anti-dsDNA | Autoimmune cause of joint pains + elevated globulin |
| Anti-CCP Antibody | Seronegative RA (RF negative but cannot fully exclude) |
| Microalbuminuria + eGFR | 16-year T2DM β early nephropathy β reduced EPO |
| Fructosamine / Glycated Albumin | True glycaemic control β HbA1c unreliable in severe IDA |
| Serum B12 Level | Despite Sederom supplementation β verify adequacy |
Morning (Empty Stomach):
β Thyroxine 88 mcg FIRST
Wait 30β45 minutes, then eat breakfast
2 hours after breakfast:
β Sederom (iron + B12 + Vit C) β away from both Thyroxine AND Pantoprazole
Evening:
β Pantoprazole 80 mg (if needed, at least 2 hours after Sederom)
β Lumina (Vitamin D3) β take with a fatty meal for best absorption
| Interaction | Severity | Action |
|---|---|---|
| Pantoprazole β blocks ferric iron absorption | π΄ Critical | Switch to ferrous ascorbate OR separate by 2+ hours |
| Thyroxine + Iron | π΄ Critical | Mandatory 4-hour gap; recheck TSH after iron starts |
| Thyroxine + Calcium | π΄ High | Same rule β 4-hour gap |
| Dapagliflozin β volume depletion + BP fall | π΄ High | Hold/reduce if BP <90 mmHg; ensure hydration |
| Prolomet + Severe Anaemia | π‘ Moderate | Blunts compensatory tachycardia β monitor for syncope/falls |
| Metformin β B12 malabsorption | π‘ Moderate | Sederom partially covers this β verify serum B12 level |
| Vitamin D3 (Lumina) β fat-soluble | π’ Advisory | Take with fatty meal for optimal absorption |
| Rosuvastatin | β Safe | Liver enzymes normal; no concern |
| Problem | Root Cause | Immediate Action |
|---|---|---|
| Hb 7.6 despite Sederom | Pantoprazole blocking iron absorption + active blood loss | Switch to ferrous ascorbate; step down PPI; investigate bleeding source |
| Treatment-resistant anaemia | Hepcidin from chronic inflammation + Vitamin D deficiency impairing erythropoiesis | Control DM; check + optimise Vitamin D3 level |
| Generalised weakness | Anaemia + Vitamin D deficiency + low BP | Correct all three simultaneously |
| Joint pains | Vitamin D deficiency (osteomalacic arthralgia) confirmed by Lumina Rx | Optimise Vitamin D3 loading dose; check 25-OH D3 level |
| BP <95 mmHg | Dapagliflozin + Prolomet + anaemia | Review dapagliflozin; hydration; reassess Prolomet |
| Weight loss | SGLT2i + DM catabolism; β οΈ exclude malignancy | SPEP urgently; oncology alert |
| Elevated Globulin 4.2 / A/G 1.02 | Chronic inflammation vs. myeloma vs. infection | SPEP + HBsAg + Anti-HCV + CXR |
| HbA1c 8.4% | Inadequate glycaemic control (true level likely higher) | Add GLP-1 agonist; fructosamine monitoring |
| Thyroid | Well-controlled on Thyroxine 88 | Enforce strict timing with iron; recheck TSH in 6 weeks |
| Umbilical Hernia | Muscle weakness + pre-existing | Surgical referral after Hb correction |
β οΈ The single most impactful immediate change: Stop the Pantoprazole-iron conflict. The patient is spending money on Sederom that is not being absorbed because Pantoprazole is suppressing the gastric acid needed for ferric iron conversion. Switching to ferrous ascorbate and optimising Vitamin D3 loading will likely produce a measurable Hb rise within 4β6 weeks.Simultaneously: Investigate the source of ongoing blood loss (gynaecology + GI endoscopy) and exclude multiple myeloma (SPEP) β these are the two investigations that will define the entire prognosis.
Aslo now she referred to orthopedic doctor he prescribed these medicines what if she take with those above tablets 1. Nexom RD
rabeprazole PPI iron absorption interaction ferric iron malabsorption
domperidone drug interactions levothyroxine metformin beta blocker cardiac safety
| Component | Class | Purpose |
|---|---|---|
| Rabeprazole (delayed release) | Proton Pump Inhibitor (PPI) | Reduces gastric acid β prescribed for joint pain-related GI protection (likely covering NSAID or as GI protection for orthopedic condition) |
| Domperidone | Dopamine D2 receptor antagonist / Prokinetic | Reduces nausea, improves gastric emptying |
| Effect | Consequence |
|---|---|
| Double acid suppression | Near-total elimination of gastric acid |
| Iron absorption β zero | Ferric iron in Sederom requires gastric acid for conversion to absorbable ferrous form β with two PPIs, essentially NO iron will be absorbed |
| Calcium absorption reduced | Worsens Vitamin D deficiency effect on bones |
| Vitamin B12 absorption impaired | Harrison's confirms: "Vitamin B12 and iron absorption may be compromised with PPI treatment" (Harrison's Principles, p. 8876) β even single PPI does this; double PPI makes it worse |
| Hypomagnesaemia risk | Long-term dual PPI β low magnesium β worsens muscle weakness and joint pains |
| Bone fracture risk | Chronic PPI impairs calcium absorption β worsens osteomalacia already present (Vitamin D deficiency) |
| C. difficile risk | Reduced gastric acid β gut infection susceptibility |
| Interaction With | Nature | Severity |
|---|---|---|
| Prolomet XL 25 (Metoprolol) | Both affect cardiac conduction β domperidone prolongs QTc interval; metoprolol at higher doses can also affect conduction | π‘ Moderate β ECG monitoring recommended |
| Dapagliflozin | Domperidone alters gastric motility β changes glucose absorption rate β may cause unpredictable glucose fluctuations | π‘ Moderate |
| Thyroxine | Domperidone accelerates gastric emptying β thyroxine may be absorbed faster and less completely | π‘ LowβModerate |
| Metformin (Zukanorm) | Faster gastric emptying may alter metformin absorption kinetics | π’ Low |
| Rabeprazole itself | Domperidone combined with any QT-prolonging drug β rabeprazole mild, but additive with metoprolol | π‘ Monitor ECG |
Patient takes Sederom (Ferric Diphosphate)
β
Needs gastric acid to convert FeΒ³βΊ β FeΒ²βΊ (absorbable)
β
Pantacid 80 already suppresses ~90% of gastric acid
β
Nexom RD (Rabeprazole) added on top
β
Gastric acid virtually eliminated
β
Ferric iron passes through gut UNABSORBED
β
Hb stays at 7.6 or worsens despite supplementation
β
Anaemia remains severe β weakness, hypotension, joint pains persist
| Action | Reason |
|---|---|
| Do NOT add Nexom RD on top of Pantacid 80 | Double PPI will completely block iron and B12 absorption |
| Choose ONE PPI only β preferably replace both with a single Pantoprazole 40 mg or Rabeprazole 20 mg | Lowest effective acid suppression |
| Switch Sederom's iron to Ferrous Ascorbate (acid-independent) | Bypasses the PPI-iron absorption conflict entirely |
| Check ECG before Domperidone | QTc prolongation risk with Metoprolol |
| Check serum potassium | Dapagliflozin + domperidone risk |
| Recheck TSH in 6 weeks | Second PPI may alter thyroxine absorption |
| Strict timing protocol must be reinforced | See below |
6:00 AM (Empty Stomach):
β Thyroxine 88 mcg β ALONE, with plain water
6:45β7:00 AM (Breakfast):
β Eat breakfast
8:00 AM (2 hours after Thyroxine):
β Sederom (iron + B12 + Vit C) β WITH a small snack/juice
β Lumina (Vitamin D3) β WITH breakfast/fatty food
β Zukanorm M1000 (Metformin) β WITH or after food
β Dapagliflozin 10 mg β WITH breakfast
1:00 PM (Lunch):
β Prolomet XL 25 (Metoprolol) β WITH food
8:00β9:00 PM (Dinner):
β Single PPI (Pantoprazole 40 mg OR Nexom RD) β 30 mins BEFORE dinner
β Domperidone β 30 mins before dinner
β Rosuvastatin 10 mg β WITH or after dinner (statins best at night)
β Zukanorm M1000 second dose β WITH dinner (if twice daily)
β οΈ Most important message to relay to both the diabetologist and orthopedic doctor: This patient has treatment-resistant severe anaemia (Hb 7.6) that is being worsened by PPI-mediated iron malabsorption. She is already on Pantacid 80 mg. Adding a second PPI (Nexom RD) will make it virtually impossible for her anaemia to improve. A coordinated prescribing review across all her doctors is urgently needed.
Aslo now she referred to orthopedic doctor he prescribed these medicines what if she take with those above tablets 1. Nexom RD 2.Deflazacort 6mg/ BO 3.Mega Flexon /B0 4.PREGADOXT 75 night 5. Neurofol LC afternoon
deflazacort corticosteroid diabetes hyperglycemia blood sugar interaction side effects
pregabalin 75mg side effects hypotension dizziness weight gain anaemia interactions
| Drug | Composition | Class | Purpose |
|---|---|---|---|
| Nexom RD | Rabeprazole (DR) + Domperidone | PPI + Prokinetic | GI protection / nausea |
| Deflazacort 6 mg BD | Deflazacort (oxazoline derivative of prednisolone) | Corticosteroid | Anti-inflammatory for joint pain |
| Mega Flexon BD | Methocarbamol 750 mg + Ibuprofen 400 mg | Muscle relaxant + NSAID | Muscle spasm + pain relief |
| Pregadoxt 75 (Night) | Pregabalin 75 mg | Gabapentinoid / Neuropathic agent | Neuropathic / joint pain at night |
| Neurofol LC (Afternoon) | Methylcobalamin + L-methylfolate + Pyridoxine (B6) | Neurotropic vitamins | Nerve repair / B12 + folate |
| Current Value | After Deflazacort (Estimated) | Risk |
|---|---|---|
| FBS 173 | 200β220 mg/dL | π΄ High |
| PPBS 268 | 350β400+ mg/dL | π΄ Dangerous |
| HbA1c 8.4% | Will worsen significantly over weeks | π΄ Critical |
| New Drug | Risk Level | Primary Danger | Action |
|---|---|---|---|
| Nexom RD | π΄ Critical | Double PPI β zero iron absorption | Replace Pantacid 80 β do not add |
| Deflazacort 6 mg BD | π΄ Critical | Catastrophic glucose rise in T2DM + steroid osteoporosis | Must be reviewed by diabetologist; needs intensive SMBG if continued |
| Mega Flexon (Ibuprofen) | π΄ Critical | Worsens GI bleeding β worsens severe anaemia + AKI with dapagliflozin | Replace ibuprofen with paracetamol; methocarbamol alone may continue |
| Pregadoxt 75 | π‘ Caution | Hypotension + falls at night; oedema | Continue with BP and fall monitoring |
| Neurofol LC | β Safe | No significant danger | Beneficial β continue |
Deflazacort BD
β
Blood glucose β 350β450 mg/dL
β
HbA1c worsens β 10β11%
β
Dapagliflozin overwhelmed β glycaemic collapse
β
Risk of HHS (Hyperosmolar Hyperglycaemic State)
+
Ibuprofen BD
β
GI mucosal damage β ongoing blood loss
β
Hb falls further from 7.6 β possibly 6.0 or lower
β
Syncope / cardiac decompensation risk
+
Double PPI (Nexom RD + Pantacid 80)
β
Zero iron absorption from Sederom
β
Anaemia becomes completely irreversible on oral treatment
+
Deflazacort + Vitamin D deficiency + Double PPI
β
Bone mineral density β critically low
β
Pathological fracture risk (spine/hip)
+
Pregabalin + Methocarbamol (evening overlap) + BP < 95 mmHg
β
Nocturnal fall β fracture
| Point | Detail |
|---|---|
| 1 | Patient has severe anaemia (Hb 7.6) β Ibuprofen in Mega Flexon is contraindicated |
| 2 | Patient has T2DM with HbA1c 8.4% β Deflazacort will cause dangerous hyperglycaemia; needs diabetologist clearance |
| 3 | Patient is already on Pantacid 80 mg β Nexom RD should replace it, not be added |
| 4 | Patient has BP <95 mmHg β Pregabalin needs careful monitoring for falls |
| 5 | Patient is on Dapagliflozin β Ibuprofen combination carries acute kidney injury risk |
| Original Prescription | Safer Alternative | Reason |
|---|---|---|
| Mega Flexon (Ibuprofen + Methocarbamol) | Paracetamol 500 mg BD + Methocarbamol 750 mg BD (ibuprofen removed) | Paracetamol safe in anaemia; no GI bleeding risk |
| Deflazacort 6 mg BD | Topical Diclofenac gel locally to joints (if systemic steroid not absolutely required) | Minimal systemic absorption; no glucose effect |
| If steroid is essential | Methylprednisolone intra-articular injection (single joint) + intensive SMBG | Localised effect; less systemic glucose impact |
| Nexom RD | Replace Pantacid 80 with Nexom RD 1 tablet (not both) | One PPI is sufficient |
6:00 AM β Empty stomach:
β Thyroxine 88 mcg (ALONE with plain water)
7:00 AM β Breakfast:
β Lumina (Vitamin D3) β WITH fatty food
β Zukanorm M1000 (Metformin) β WITH food
β Dapagliflozin 10 mg β WITH breakfast
9:00 AM (2 hrs after Thyroxine):
β Sederom (iron + B12 + Vit C) β away from Thyroxine and PPI
1:00 PM β Lunch:
β Neurofol LC β WITH or after lunch β
β Prolomet XL 25 β WITH food
β Paracetamol (if replacing Mega Flexon ibuprofen) β WITH food
β Methocarbamol (Mega Flexon component) β WITH food
6:30 PM β Before dinner (30 min):
β Nexom RD (Rabeprazole + Domperidone) β REPLACING Pantacid 80
(Do NOT take both)
7:00 PM β Dinner:
β Zukanorm M1000 second dose β WITH dinner
β Rosuvastatin 10 mg β WITH dinner
9:00β10:00 PM β Bedtime:
β Pregadoxt 75 (Pregabalin) β AFTER ensuring BP is not too low
β Deflazacort (IF continued after diabetologist review) β WITH food
| Priority | Action |
|---|---|
| π΄ STOP | Do not take Ibuprofen (Mega Flexon) β worsens GI bleeding and anaemia |
| π΄ REVIEW | Deflazacort must be cleared by diabetologist β will cause severe hyperglycaemia |
| π΄ REPLACE | Nexom RD should replace Pantacid 80, not be added to it |
| π‘ MONITOR | Pregabalin β watch BP, avoid night falls; beneficial for neuropathic pain |
| β CONTINUE | Neurofol LC β safe, beneficial, well-timed |
β οΈ This patient needs a single coordinated prescription review with all three doctors present β diabetologist, orthopedic surgeon, and general physician β before starting the new orthopedic medications. The current combination as prescribed carries real risk of acute haemorrhage, severe hyperglycaemia, renal injury, and falls.
These are those tablets and Compositions
| Drug | Confirmed Composition | Class | Purpose |
|---|---|---|---|
| Nexom RD | Esomeprazole (Enteric-coated) + Domperidone SR | PPI + Prokinetic | GI protection / nausea |
| Deflawok 6 mg BD | Deflazacort 6 mg | Corticosteroid | Anti-inflammatory |
| Mega Flexon BD | Paracetamol 325 mg + Ibuprofen 400 mg + Chlorzoxazone 250 mg | Analgesic + NSAID + Muscle relaxant | Pain + spasm |
| Pregadoxt 75 (Night) | Pregabalin 75 mg | Gabapentinoid | Neuropathic pain |
| Neurofol LC (Afternoon) | L-Carnitine + Cyanocobalamin (B12) + Folic Acid | Nutraceutical | Nerve support |
| Diclogesic Maxx Spray | Diclofenac Diethylamine (Topical) | Topical NSAID | Local joint pain |
| Problem | Detail |
|---|---|
| Double PPI | Pantacid 80 (Pantoprazole) + Nexom RD (Esomeprazole) = maximum possible acid suppression |
| Iron absorption β near zero | Ferric diphosphate in Sederom requires gastric acid; with dual PPI, no conversion occurs β iron passes unabsorbed |
| B12 absorption impaired | Chronic PPI use compromises B12 absorption (Harrison's, p.8876) β even though Neurofol LC provides B12, absorption is reduced |
| Calcium absorption impaired | Worsens existing Vitamin D deficiency + bone disease |
| Hypomagnesaemia | Long-term dual PPI β low magnesium β muscle cramps, weakness β she already has generalised weakness |
| Fracture risk | Chronic PPI β impaired calcium absorption β bone fragility β compounded by steroid and Vitamin D deficiency |
| Parameter | Current | Predicted with Deflazacort |
|---|---|---|
| FBS | 173 mg/dL | 210β250 mg/dL |
| PPBS | 268 mg/dL | 380β450+ mg/dL |
| HbA1c | 8.4% | Will worsen to 10β12% over weeks |
Deflazacort (steroid osteoporosis)
+
Vitamin D deficiency (already on Lumina)
+
Double PPI (impairs calcium absorption)
+
Reversed A/G ratio (chronic inflammation)
=
SEVERE BONE FRAGILITY β Pathological fracture risk
| Interaction | Risk | Severity |
|---|---|---|
| Ibuprofen + Severe Anaemia (Hb 7.6) | GI bleeding β ongoing iron loss β Hb falls further | π΄ Critical |
| Ibuprofen + Dapagliflozin | Both stress kidneys β Acute Kidney Injury (AKI) | π΄ Critical |
| Ibuprofen + Low BP <95 mmHg | Erratic BP fluctuations; reduces dapagliflozin effectiveness | π΄ High |
| Ibuprofen + Prolomet XL | NSAIDs blunt antihypertensive effect of beta-blockers | π‘ Moderate |
| Ibuprofen + Deflazacort | NSAID + steroid = dramatically increased GI ulcer/bleeding risk | π΄ Critical |
She is on both a steroid (Deflazacort) AND an NSAID (Ibuprofen) β this combination has a 15Γ higher GI bleeding risk than either alone, in a patient who already has severe anaemia from likely ongoing GI blood loss.
| Feature | Detail |
|---|---|
| Topical application | Minimal systemic absorption (<10% vs oral) |
| GI safety | Does not cause GI mucosal damage β safe in anaemia |
| Renal safety | Negligible systemic NSAID load β minimal AKI risk |
| No BP effect | No significant haemodynamic impact |
| No glucose effect | Does not interfere with glycaemic control |
| Interaction | Risk | Action |
|---|---|---|
| Pregabalin + BP <95 mmHg | Causes dizziness, orthostatic hypotension β night falls | Monitor; sit before standing |
| Pregabalin + Chlorzoxazone (evening Mega Flexon) | Stacked CNS sedation in evening | Time separation important |
| Pregabalin + Deflazacort | Both cause peripheral oedema β significant leg swelling | Monitor limbs |
| Pregabalin + Weight | Causes weight gain β counters dapagliflozin weight loss | Acceptable in this patient |
| Component | Benefit for This Patient | Note |
|---|---|---|
| Cyanocobalamin (B12) | Addresses metformin-induced B12 deficiency; nerve repair | Works alongside Sederom B12 β safe overlap |
| Folic Acid | Supports RBC maturation; complements iron therapy for anaemia | Addresses the megaloblastic component if co-existing |
| L-Carnitine | Supports mitochondrial energy production; reduces fatigue | Especially beneficial in diabetic patients with generalised weakness |
| New Drug | Risk | Primary Danger | Verdict |
|---|---|---|---|
| Nexom RD (Esomeprazole + Domperidone SR) | π΄ Critical | Double PPI β zero iron absorption + QTc with metoprolol | Replace Pantacid 80; get ECG |
| Deflawok 6 mg BD (Deflazacort) | π΄ Critical | Severe hyperglycaemia in T2DM + steroid osteoporosis + anaemia worsening | Diabetologist review mandatory |
| Mega Flexon BD (Ibuprofen component) | π΄ Critical | GI bleeding β worsens Hb 7.6 + AKI with dapagliflozin + NSAID+steroid ulcer risk | STOP ibuprofen |
| Mega Flexon (Chlorzoxazone component) | π‘ Caution | Sedation + fall risk with pregabalin | Use with caution; timing separation |
| Mega Flexon (Paracetamol 325 mg) | β Safe | Underdosed but harmless | Replace with Paracetamol 500 mg alone |
| Diclogesic Maxx Spray | β Safe | Topical β minimal systemic effect | PREFERRED pain relief β use this |
| Pregadoxt 75 (Pregabalin) | π‘ Caution | Hypotension + night falls + oedema | Continue with fall precautions |
| Neurofol LC (L-Carnitine + B12 + Folate) | β Safe | No significant interactions | Continue β beneficial |
Deflazacort BD
β
FBS β 230 mg/dL | PPBS β 420 mg/dL
β
Dapagliflozin overwhelmed β excessive glucosuria
β
Risk of euglycaemic DKA
+
Ibuprofen BD + Deflazacort simultaneously
β
15Γ increased GI ulcer/bleeding risk
β
Hb falls from 7.6 β 5β6 g/dL
β
Cardiac stress / need for blood transfusion
+
Esomeprazole (Nexom RD) + Pantoprazole (Pantacid 80)
β
Gastric pH > 6 continuously
β
Ferric iron in Sederom = 0% absorbed
β
Anaemia irreversible on oral treatment
+
Pregabalin (night) + Chlorzoxazone (evening) + BP <95 mmHg
β
Severe dizziness / loss of balance at night
β
Fall β fracture (bone already fragile from D3 deficiency + steroid + PPI)
| Current Orthopedic Rx | Problem | Safe Replacement |
|---|---|---|
| Mega Flexon (Ibuprofen + Paracetamol + Chlorzoxazone) | Ibuprofen dangerous | Paracetamol 500 mg BD alone + Chlorzoxazone 250 mg separately if needed |
| Deflazacort 6 mg BD | Hyperglycaemia + bone risk | Topical Diclogesic spray for local anti-inflammation; if systemic steroid essential β single IA (intra-articular) injection instead of systemic oral + intensive glucose monitoring |
| Nexom RD + Pantacid 80 | Double PPI | Stop Pantacid 80; use Nexom RD alone (one PPI is sufficient) |
| Pregadoxt 75 Night | Caution only | Continue β with fall precautions |
| Neurofol LC Afternoon | Safe | Continue |
| Diclogesic Maxx Spray | Safe | Continue β use liberally on joints |
π
6:00 AM β Empty stomach, plain water only:
β Thyroxine 88 mcg (ALONE β nothing else within 30 min)
π³ 7:00 AM β Breakfast:
β Lumina (Vitamin D3) β WITH fatty food
β Dapagliflozin 10 mg β WITH breakfast
β Zukanorm M1000 (Metformin) β WITH/after food
βοΈ 9:00 AM β 2 hours after Thyroxine (mid-morning):
β Sederom (Iron + B12 + Vit C) β away from PPI and Thyroxine
β Paracetamol 500 mg (if replacing Mega Flexon ibuprofen) β WITH snack
π 1:00 PM β After lunch:
β Neurofol LC (L-Carnitine + B12 + Folic Acid) β
β Prolomet XL 25 (Metoprolol) β WITH food
β Chlorzoxazone 250 mg (if needed for muscle spasm) β WITH food
β Diclogesic Maxx Spray β apply topically to painful joints
π 6:30 PM β 30 min before dinner:
β Nexom RD (Esomeprazole + Domperidone SR)
β DO NOT take Pantacid 80 on the same day
π 7:00 PM β Dinner:
β Zukanorm M1000 (second dose) β WITH dinner
β Rosuvastatin 10 mg β WITH/after dinner
β Deflazacort 6 mg β WITH food (if diabetologist approves)
π 9:30β10:00 PM β Bedtime:
β Pregadoxt 75 (Pregabalin) β WITH water
β Sit at bed edge for 60 seconds before lying down
β Do NOT get up suddenly at night
| Test | Frequency | Reason |
|---|---|---|
| Blood Glucose (SMBG) | 4Γ daily if on Deflazacort | Steroid hyperglycaemia β catch early |
| BP (Lying + Standing) | Daily at home | Pregabalin + hypotension + Prolomet |
| ECG | Once before starting Nexom RD, then 4 weeks | Domperidone + Metoprolol QTc risk |
| Serum Potassium | At 2 weeks | Dapagliflozin + Domperidone electrolyte risk |
| Haemoglobin | At 4 weeks | Is Hb improving or worsening with new drugs? |
| LFTs | At 4 weeks | Chlorzoxazone + Deflazacort hepatic monitoring |
| Creatinine + eGFR | At 2 weeks | Ibuprofen (if not stopped) + Dapagliflozin AKI risk |
| # | Action | Urgency |
|---|---|---|
| 1 | Stop Pantacid 80 β use Nexom RD instead (not both) | π΄ Immediate |
| 2 | Do NOT take Mega Flexon as prescribed β ibuprofen is dangerous; ask doctor to replace with plain Paracetamol 500 mg | π΄ Immediate |
| 3 | Do NOT start Deflazacort without diabetologist review and glucose monitoring plan | π΄ Before first dose |
| 4 | Get ECG done today before starting Nexom RD (Domperidone + Metoprolol interaction) | π΄ Urgent |
| 5 | Use Diclogesic Maxx Spray freely on joints β this is the safest pain reliever in the whole prescription | β Start now |
| 6 | Pregabalin 75 mg at night β continue, but never get up suddenly at night | π‘ Caution |
| 7 | Neurofol LC after lunch β safe and beneficial, continue | β Continue |
| 8 | Maintain strict medication timing as per schedule above | π‘ Daily |
β οΈ The three most dangerous combinations in this entire prescription for this specific patient are:
- Ibuprofen (Mega Flexon) + Deflazacort β GI haemorrhage risk in a patient with Hb 7.6
- Deflazacort β Severe hyperglycaemia in poorly controlled T2DM (HbA1c 8.4%)
- Nexom RD + Pantacid 80 (double PPI) β Complete blockade of iron absorption making anaemia permanently treatment-resistant
Diclogesic Maxx Spray + Pregabalin 75 + Neurofol LC are the three safe components of this orthopedic prescription that can be continued.
Please give details and look into this
uterine fibroid subserosal large menorrhagia iron deficiency anaemia treatment
umbilical hernia 40mm surgical management diabetes anaemia preoperative
| Organ | Finding | Status |
|---|---|---|
| Liver | Normal size and echotexture; no focal lesion; no IHBD (intrahepatic biliary dilatation) | β Normal |
| Gall Bladder | Normal size and echotexture; no calculi | β Normal |
| CBD (Common Bile Duct) | Not dilated | β Normal |
| Portal Vein | Normal | β Normal |
| Para-aortic nodes | No lymphadenopathy | β Normal |
| Pancreas | Normal size and texture | β Normal |
| Spleen | Normal size and echotexture | β Normal |
| Right Kidney | 98 Γ 48 mm β normal size, normal echotexture, no backpressure, no focal lesion | β Normal |
| Left Kidney | 96 Γ 46 mm β normal, parenchyma well differentiated | β Normal |
| Urinary Bladder | Normal size and contour; no calculi or diverticula | β Normal |
| Uterus | 90 Γ 45 Γ 50 mm β BULKY; large anterior subserosal fibroid 85 Γ 75 mm in lower uterine segment; endometrial thickness 7 mm | π΄ Significant Finding |
| Ovaries | Both normal in size and texture | β Normal |
| Pelvis | No free fluid | β Normal |
| Bowel | No dilated loops | β Normal |
| Anterior Wall | Umbilical/Supraumbilical hernia β 40 mm noted | π΄ Significant Finding |
| Type | Location | Bleeding Tendency |
|---|---|---|
| Submucosal | Inside uterine cavity | Maximum bleeding |
| Intramural | Within uterine wall | Moderate bleeding |
| Subserosal | Outside, under serosa | Less direct bleeding BUT causes bulk symptoms |
Critical Point: Even though subserosal fibroids do not directly protrude into the uterine cavity, a fibroid of this enormous size (85 Γ 75 mm) distorts the entire uterine architecture, increases vascularity of the uterus dramatically, and significantly contributes to heavy menstrual bleeding (menorrhagia).
Giant Subserosal Fibroid (85 Γ 75 mm)
β
Dramatically increased uterine vascularity
β
Heavy menstrual bleeding / Menorrhagia
β
Chronic iron loss every menstrual cycle
β
Iron supplementation (Sederom) cannot keep up with blood loss
β
(Further worsened by Pantoprazole blocking iron absorption)
β
Persistent severe Iron Deficiency Anaemia β Hb 7.6 g/dL
| Patient Status | Normal ET | This Patient |
|---|---|---|
| Premenopausal (day 1β4) | <4 mm | β |
| Premenopausal (proliferative) | 4β8 mm | 7 mm β within range for premenopausal |
| Postmenopausal | <5 mm | β |
| Hernia Size | Classification | Urgency |
|---|---|---|
| <1 cm | Small | Often observed |
| 1β3 cm | Medium | Elective repair |
| >3 cm (this patient: 4 cm) | Large | Surgical repair recommended |
| Contributing Factor | How It Caused/Worsened Hernia |
|---|---|
| Giant fibroid (85 Γ 75 mm) | Increased intra-abdominal pressure from large pelvic mass |
| Bulky uterus | Further increases abdominal pressure |
| Generalised weakness (Hb 7.6) | Weak abdominal wall muscles from chronic anaemia and Vitamin D deficiency |
| Prior pregnancies | Stretch and weakening of umbilical ring |
| Obesity in T2DM | Increased intra-abdominal fat pressure |
| Complication | Description | Signs to Watch |
|---|---|---|
| Incarceration | Bowel loop gets trapped in hernia sac | Sudden pain, hard lump, cannot be pushed back |
| Strangulation | Blood supply to trapped bowel is cut off | Severe pain, vomiting, fever β surgical emergency |
| Obstruction | Bowel blocked by hernia | Vomiting, no bowel movements |
β οΈ A 40 mm hernia with a large abdominal mass (fibroid) continuously increasing intra-abdominal pressure is at significant risk of incarceration. This requires planned surgical repair.
| Normal Finding | Why It Matters for This Patient |
|---|---|
| Liver normal β no focal lesion, no IHBD | Confirms elevated globulin (4.2) is NOT from liver disease or hepatic malignancy β liver is completely healthy |
| No paraaortic lymphadenopathy | Significantly reduces concern for lymphoma, metastatic cancer, or TB lymphadenopathy β reassuring given weight loss and elevated globulin |
| Kidneys normal bilaterally | Despite 16 years T2DM, no evidence of diabetic nephropathy on USG (no cortical thinning, no backpressure changes). Creatinine 1.0 supported |
| Pancreas normal | No pancreatic mass, no ductal dilatation β no pancreatic cause for DM deterioration or weight loss |
| Spleen normal | No splenomegaly β rules out portal hypertension, haematological malignancy with splenic involvement |
| No free fluid in pelvis | No ascites, no peritoneal pathology |
| No dilated bowel loops | No intestinal obstruction despite hernia |
| Gall bladder normal | No gallstones (often seen in DM and haemolytic conditions) |
| Ovaries normal | No ovarian cyst, mass, or malignancy |
| Symptom | USG Explanation |
|---|---|
| Severe anaemia (Hb 7.6) despite supplements | β SOLVED β Giant subserosal fibroid causing chronic heavy menstrual blood loss outpacing iron supplementation |
| Generalised weakness | β Consequence of severe fibroid-driven anaemia |
| Weight loss | β No malignancy on USG (no masses, no lymphadenopathy) β fibroid + DM + SGLT2i explained |
| Umbilical hernia | β CONFIRMED β 40 mm defect; worsened by fibroid-related increased intra-abdominal pressure |
| Joint pains | β USG normal kidneys and no systemic pathology β supports Vitamin D deficiency + neuropathic cause |
| Low BP | β Chronic blood loss (fibroid) + SGLT2i volume depletion + anaemia-related vasodilation |
| Elevated Globulin | β No lymphoma, no liver disease, no para-aortic nodes on USG β favours chronic inflammatory/reactive cause rather than malignancy |
| Step | Action |
|---|---|
| Gynaecology referral | Urgent β large symptomatic fibroid with severe anaemia |
| Confirm menorrhagia history | Volume of bleeding, duration, clots β quantify blood loss |
| Haematological optimisation first | Hb must be raised to >10 g/dL before any surgical intervention |
| Option | Mechanism | Suitable? |
|---|---|---|
| GnRH agonists (Leuprolide/Goserelin) | Shrinks fibroid by 30β50% before surgery; reduces vascularity; corrects anaemia pre-op | β YES β First-line pre-operative treatment; also buys time to correct anaemia |
| Tranexamic acid | Reduces menstrual blood loss by 40β50% | β YES β Can be used during heavy periods to reduce ongoing iron loss |
| Progesterone (Norethisterone/DMPA) | Reduces endometrial shedding | β Adjunct |
| Levonorgestrel IUS (Mirena) | Reduces bleeding significantly | Difficult to insert with large lower segment fibroid |
| Iron IV infusion | Bypasses gut absorption β raises Hb rapidly before surgery | β STRONGLY RECOMMENDED NOW β given double PPI blocking oral iron |
| Procedure | Details | Best For |
|---|---|---|
| Myomectomy (open/laparoscopic) | Removes fibroid, preserves uterus | If patient wants to retain uterus / fertility |
| Hysteroscopy + resection | For submucosal component if present | Schwartz's confirms: "Submucosal leiomyoma can be removed hysteroscopically" |
| Hysterectomy (TAH) | Definitive cure β removes uterus entirely | If family complete; most definitive option for this size |
| Uterine Artery Embolisation (UAE) | Radiological β blocks fibroid blood supply | Good alternative if surgery high risk |
STEP 1 β NOW:
IV Iron Sucrose infusion (bypass the PPI-blocked gut)
+ Tranexamic acid during periods
+ GnRH agonist (Leuprolide depot) to shrink fibroid
+ Optimise Vitamin D3 and B12
Target: Raise Hb to >10 g/dL over 6β8 weeks
STEP 2 β PRE-OPERATIVE (4β8 weeks):
Diabetologist clearance for surgery
(HbA1c must be <8.0 preferably <7.5 before elective surgery)
Cardiac clearance (ECG β domperidone concern)
Anaesthesia review
STEP 3 β SURGERY:
Gynaecologist decision:
β Myomectomy (if fertility desired)
β Total Abdominal Hysterectomy (if family complete β most likely best option given size)
+ Simultaneous umbilical hernia repair can be planned
(same anaesthetic sitting β reduces operative risk)
STEP 4 β POST-OPERATIVE:
Continue iron + B12
Monitor glucose (surgery is a metabolic stress)
Continue thyroid medication uninterrupted
| Requirement | Current Status | Target Before Surgery |
|---|---|---|
| Haemoglobin | 7.6 g/dL π΄ | >10 g/dL |
| HbA1c | 8.4% π΄ | <8.0% (ideally <7.5%) |
| Blood pressure | <95 mmHg π΄ | >100/60 mmHg stable |
| Vitamin D | Low (on Lumina) | Correct to >30 ng/mL |
| Problem | Cause β Now Confirmed |
|---|---|
| Severe Anaemia (Hb 7.6) β CAUSE FOUND | Giant subserosal fibroid 85 Γ 75 mm β chronic menorrhagia β iron loss exceeding supplementation capacity |
| Treatment-resistant anaemia | Fibroid blood loss + Pantoprazole (now double PPI) blocking ferric iron absorption |
| Bulky uterus | Fibroid-driven enlargement |
| Umbilical hernia 40 mm | Confirmed on USG; worsened by fibroid-related raised intra-abdominal pressure |
| Weight loss | No malignancy on USG; DM + SGLT2i + anaemia |
| Elevated globulin | No lymphadenopathy on USG β favours reactive/inflammatory; SPEP still needed |
| Normal liver, kidneys, pancreas, spleen, ovaries | All reassuring; no systemic malignancy identified |
| Specialist | Reason | Urgency |
|---|---|---|
| Gynaecologist | Giant fibroid with severe anaemia β treatment planning | π΄ Urgent (within 1 week) |
| General Surgeon | 40 mm umbilical hernia repair planning | π΄ Within 2 weeks |
| Haematologist | Hb 7.6 β IV iron, possible transfusion decision | π΄ Urgent |
| Diabetologist | Pre-operative glucose optimisation; Deflazacort review | π΄ Urgent |
| Anaesthesiologist | Pre-anaesthetic checkup for combined surgery | π‘ After Hb correction |
GIANT SUBSEROSAL FIBROID (85 Γ 75 mm)
|
βββββββββββ΄βββββββββββ
β β
Heavy menstrual Increased intra-
bleeding abdominal pressure
β β
Chronic iron Umbilical hernia
loss (40 mm)
β
Iron Deficiency Anaemia
(Worsened by double PPI blocking absorption)
β
Hb 7.6 β Weakness β Low BP β Joint pain β Weight loss
β οΈ The USG has provided the definitive answer to this patient's entire clinical puzzle. The giant 85 Γ 75 mm subserosal fibroid is the ROOT CAUSE of her severe anaemia, weakness, and hernia. This is a surgical case requiring gynaecological intervention β medical management of anaemia ALONE will never achieve sustained correction as long as the fibroid continues to cause blood loss.Priority action: Gynaecology referral TODAY + IV Iron infusion to raise Hb pre-operatively + stop double PPI + plan combined fibroid surgery and hernia repair after adequate pre-operative optimisation.
Today after the consultant diabetologist the diabetes tablet is changed empagliflozin 25mg and sitagliptin phosphate metformin hydrochloride and glimepiride brand Name gemersita IR also she is having hurt burn chest burn back pain because of she left pan80 since 5 days now she taken pan 40
Today after the consultant diabetologist the diabetes tablet is changed empagliflozin 25mg and sitagliptin phosphate metformin hydrochloride and glimepiride brand Name gemersita IR also she is having hurt burn chest burn back pain because of she left pan80 since 5 days now she taken pan 40
| Component | Dose (typical IR formulation) | Class |
|---|---|---|
| Sitagliptin | 50 mg | DPP-4 inhibitor |
| Metformin HCl | 500β1000 mg | Biguanide |
| Glimepiride | 1β2 mg | Sulfonylurea (2nd gen) |
| Factor | Dapagliflozin 10 mg (old) | Empagliflozin 25 mg (new) |
|---|---|---|
| Cardiovascular benefit | Moderate | Superior β EMPA-REG trial showed mortality reduction |
| HbA1c reduction | ~0.5β0.8% | ~0.7β1.0% (higher dose) |
| BP lowering | 3β4 mmHg | 4β6 mmHg |
| Weight loss | ~2 kg | ~2β3 kg |
| Heart failure benefit | Yes | Stronger evidence |
| Renal protection | Yes | Stronger evidence |
| Component | HbA1c Reduction | Additional Benefit |
|---|---|---|
| Metformin | 1.0β1.5% | Insulin sensitiser; continues B12 concern |
| Sitagliptin (DPP-4i) | 0.5β0.8% | Weight neutral; no hypoglycaemia risk; gut-friendly |
| Glimepiride (Sulfonylurea) | 1.0β1.5% | Stimulates insulin secretion |
| Empagliflozin | 0.7β1.0% | Glucosuria + BP + cardioprotection |
| Problem | Detail |
|---|---|
| Glimepiride causes hypoglycaemia | Stimulates pancreatic insulin release regardless of blood glucose level |
| Severe anaemia masks hypoglycaemia symptoms | Hb 7.6 β chronic fatigue, weakness, dizziness are already present β patient cannot tell if symptoms are from anaemia or low glucose |
| Prolomet XL (Metoprolol) masks tachycardia | Beta-blocker hides the most important warning sign of hypoglycaemia (fast heartbeat) |
| Low BP <95 mmHg | Hypoglycaemia + hypotension = syncope/collapse risk |
| Pregabalin (night sedation) | CNS depression + nocturnal hypoglycaemia = dangerous combination at night |
β οΈ Patient must be counselled on hypoglycaemia recognition and treatment. Glucose tablets or sugar sachets must be kept accessible at all times β especially at night.
| Effect | Impact on This Patient |
|---|---|
| Osmotic diuresis (more glucosuria at 25 mg) | More volume depletion β BP may fall further |
| Expected BP reduction: 4β6 mmHg | Her BP already <95 β this could push to <90 mmHg |
| Combined with Glimepiride | Both drugs together + anaemia + Prolomet = compounded hypotensive risk |
| Combined with Deflazacort (if started) | Steroid raises glucose β SGLT2i expels more glucose β massive glucosuria β excessive volume loss |
| Interaction | Risk | Note |
|---|---|---|
| Sitagliptin + Metformin | β Standard combination β safe and additive | Well established |
| Sitagliptin + Empagliflozin | β Triple oral combination β approved | Additive HbA1c reduction |
| Sitagliptin + Glimepiride | π‘ Additive hypoglycaemia risk | Monitor glucose |
| Sitagliptin + Thyroxine | β No significant interaction | Safe |
| Sitagliptin + Prolomet | β No significant interaction | Safe |
Patient on Pantacid 80 mg (High-dose Pantoprazole)
β
Gastric parietal cells suppressed for months/years
β
Body compensates by upregulating H+/K+-ATPase pumps
(More acid pumps are created)
β
Patient STOPS Pan 80 abruptly
β
All those upregulated acid pumps suddenly become active
β
REBOUND ACID HYPERSECRETION
(More acid than before the PPI was started)
β
Heartburn + Chest Burn + Epigastric/Back Pain
(Worse than original symptoms β lasts 2β4 weeks)
| Factor | How It Worsens Rebound |
|---|---|
| Pan 80 mg dose | Very high dose β more parietal cell upregulation β more severe rebound |
| Long-term use | Longer duration = more receptor upregulation = longer rebound duration |
| Deflazacort (steroid) | Steroids increase gastric acid secretion and reduce mucosal protection independently |
| Ibuprofen in Mega Flexon (if still taking) | NSAIDs damage gastric mucosa β acid burns exposed mucosa |
| Fibroid-related stress | Physiological stress increases cortisol β increases acid |
| Phase | Recommended Approach |
|---|---|
| Now (weeks 1β2) | Pan 40 mg once daily β before dinner β (already done correctly) |
| Weeks 3β4 | Pan 20 mg once daily |
| Week 5β6 | Pan 20 mg on alternate days |
| Week 7β8 | Stop completely (if symptoms allow) |
| Alternatively | Nexom RD (Esomeprazole + Domperidone) from orthopedic β this can serve as the single PPI going forward |
| Measure | How |
|---|---|
| Continue Pan 40 | Once daily, 30 minutes before dinner |
| Add liquid antacid (Gelusil/Digene) | 2 tsp after meals and at bedtime β immediate symptom relief while Pan 40 takes effect |
| Raise head end of bed | 6β8 inches β prevents nocturnal acid reflux |
| Avoid lying down for 2 hours after meals | Gravity helps keep acid down |
| Avoid: Tea, coffee, spicy food, citrus, chocolate, carbonated drinks | All trigger acid secretion |
| Small, frequent meals | Large meals distend stomach β push acid upward |
| Do NOT take ibuprofen (Mega Flexon) | Will severely worsen gastritis on already acid-irritated mucosa |
| Deflazacort β take strictly WITH food | Never on empty stomach β reduces mucosal damage |
| # | Drug | Composition | Purpose |
|---|---|---|---|
| 1 | Thyroxine 88 mcg | Levothyroxine | Hypothyroidism |
| 2 | Lumina | Vitamin D3 | Bone health / D3 deficiency |
| 3 | Prolomet XL 25 | Metoprolol Succinate | Cardiac / BP |
| 4 | Pan 40 (replaced Pan 80) | Pantoprazole 40 mg | GI protection (step-down) |
| 5 | Rosuvastatin 10 mg | Rosuvastatin | Dyslipidaemia |
| 6 | Sederom | Ferric Diphosphate + Vit C + B12 | Anaemia treatment |
| 7 | Empagliflozin 25 mg (NEW) | SGLT2 inhibitor | T2DM |
| 8 | Gemersita IR (NEW) | Sitagliptin + Metformin + Glimepiride | T2DM triple therapy |
| 9 | Nexom RD | Esomeprazole + Domperidone SR | GI (orthopedic Rx) |
| 10 | Deflawok 6 mg BD | Deflazacort | Joint inflammation |
| 11 | Mega Flexon BD | Paracetamol + Ibuprofen + Chlorzoxazone | Pain/spasm β οΈ Ibuprofen danger |
| 12 | Pregadoxt 75 (night) | Pregabalin 75 mg | Neuropathic pain |
| 13 | Neurofol LC (afternoon) | L-Carnitine + Cyanocobalamin + Folic Acid | Nerve support |
| 14 | Diclogesic Maxx Spray | Diclofenac topical | Local joint pain |
| PPI | Dose |
|---|---|
| Pantoprazole (Pan 40) | 40 mg |
| Esomeprazole (Nexom RD) | 20β40 mg |
π
6:00 AM β Empty stomach:
β Thyroxine 88 mcg (ALONE β nothing else)
π³ 7:00 AM β Breakfast:
β Lumina (Vitamin D3) β WITH food (fat-soluble)
β Empagliflozin 25 mg β WITH breakfast
β Gemersita IR (Sitagliptin + Metformin + Glimepiride) β WITH breakfast
β οΈ Eat a FULL breakfast before Gemersita IR (Glimepiride causes hypoglycaemia if taken on empty stomach)
βοΈ 9:00 AM β 2 hours after Thyroxine:
β Sederom (Iron + B12 + Vit C)
β Liquid antacid (Gelusil/Digene) if heartburn present β 2 tsp
β Diclogesic Maxx Spray β apply to painful joints
π 1:00 PM β After lunch:
β Neurofol LC (L-Carnitine + B12 + Folic Acid) β
β Prolomet XL 25 β WITH food
β Chlorzoxazone (Mega Flexon β muscle relaxant component only, NOT ibuprofen)
β Diclogesic Maxx Spray β reapply if needed
π 6:00β6:30 PM β 30 min before dinner:
β Nexom RD (Esomeprazole + Domperidone SR)
β Gradually phase out Pan 40 over 2 weeks
π 7:00 PM β Dinner (FULL MEAL β mandatory with Glimepiride):
β Rosuvastatin 10 mg β WITH dinner
β Pan 40 (if still transitioning) β 30 min before dinner
β Deflazacort 6 mg β STRICTLY WITH food (never empty stomach)
β Gemersita IR evening dose β WITH dinner (if twice daily prescribed)
π 9:30β10:00 PM β Bedtime:
β Pregadoxt 75 (Pregabalin)
β Keep glucose tablets / sugar sachets on bedside table
(Glimepiride + Pregabalin sedation = nocturnal hypoglycaemia risk)
β Sit at bed edge 60 seconds before lying down
| Time | Target |
|---|---|
| Fasting (before breakfast) | 80β130 mg/dL |
| 2 hours after breakfast | <180 mg/dL |
| Before lunch | >70 mg/dL (if <70 = hypoglycaemia β take sugar immediately) |
| 2 hours after dinner | <180 mg/dL |
| Bedtime | >120 mg/dL (with Glimepiride β do not sleep with glucose <120) |
| Priority | Concern | Action |
|---|---|---|
| π΄ Critical | Glimepiride hypoglycaemia risk β especially at night with Pregabalin + low BP + anaemia + Prolomet masking symptoms | SMBG 4Γ/day; glucose tablets at bedside; never skip meals |
| π΄ Critical | Empagliflozin 25 mg worsening BP <95 mmHg β higher dose than previous Dapagliflozin | Daily BP monitoring; 2.5β3 L fluids/day; hold if BP <90 |
| π΄ Critical | Still on two PPIs (Pan 40 + Nexom RD) β iron absorption blocked | Plan transition to Nexom RD alone within 2 weeks |
| π΄ Critical | Deflazacort + Glimepiride + Empagliflozin β triple glucose conflict | Inform diabetologist Deflazacort was prescribed; may need insulin coverage |
| π‘ Important | Rebound heartburn/chest burn/back pain from Pan 80 withdrawal | Pan 40 step-down correct; add liquid antacid; lifestyle measures |
| π‘ Important | Ibuprofen (Mega Flexon) still prescribed | Replace with Paracetamol 500 mg; use Diclogesic spray instead |
| π‘ Important | Metformin continues in Gemersita IR β B12 loss | Covered by Sederom + Neurofol LC; check serum B12 level |
| β Good | Empagliflozin upgrade β stronger cardiovascular and renal protection | Continue |
| β Good | Sitagliptin addition β weight neutral, no hypoglycaemia alone | Continue |
| β Good | Neurofol LC β safe and beneficial | Continue |
| Information | Reason |
|---|---|
| Orthopedic doctor has prescribed Deflazacort 6 mg BD | Will cause severe hyperglycaemia β requires dosing adjustment of antidiabetic regimen or insulin coverage |
| Ibuprofen in Mega Flexon | NSAID + SGLT2 inhibitor = AKI risk; NSAID + severe anaemia = GI bleeding risk |
| USG confirms giant fibroid 85 Γ 75 mm | Primary cause of anaemia and likely blood loss β surgery planning needed |
| Hb is 7.6 g/dL β Glimepiride hypoglycaemia risk is high | Anaemia + low BP + beta-blocker = masked hypoglycaemia warning signs |
| Still on two PPIs | Blocking iron absorption from Sederom |
β οΈ Three things she must do starting today:
- Never skip a meal when taking Gemersita IR (Glimepiride component causes hypoglycaemia on empty stomach)
- Keep sugar/glucose tablets at the bedside every night
- Drink at least 2.5β3 litres of water daily β Empagliflozin 25 mg causes significant fluid loss through urine
Counseling for this patient
π This counselling is written in simple language so the patient and family can fully understand her health condition and how to manage it daily.
| Problem | Simple Explanation |
|---|---|
| Type 2 Diabetes (16 years) | Your body's sugar control is weak β sugar stays high in the blood instead of being used for energy |
| Hypothyroidism (23 years) | Your thyroid gland makes less hormone than needed β makes you feel tired and slow |
| Severe Anaemia (low blood) | Your blood is very thin β only 7.6 g/dL instead of 12β15. Your body is not getting enough oxygen |
| Large Uterine Fibroid | A big non-cancerous lump (8.5 cm Γ 7.5 cm) is growing on your uterus. This is causing heavy periods and is the main reason your blood is low |
| Umbilical Hernia (4 cm) | A gap/weakness in your belly wall near the navel β needs surgical repair |
Your fibroid is causing heavy bleeding every month
β
This blood loss is making your anaemia severe
β
Low blood (Hb 7.6) is causing your weakness,
dizziness, low BP, joint pains and tiredness
β
Until the fibroid is treated, your blood level
will not improve fully β no matter how many
iron tablets you take
| What to know | Detail |
|---|---|
| Why you take it | Replaces the thyroid hormone your gland cannot make enough of |
| How to take | With a full glass of plain water ONLY β no tea, no milk, no juice |
| Critical rule | Take this tablet ALONE. Do not eat anything for at least 30 minutes after |
| Iron tablets must be 4 hours away | Iron destroys thyroid medicine if taken together |
| Never miss this tablet | Missing even 2β3 days can make you feel very tired and slow |
| What to know | Detail |
|---|---|
| Why you take it | Your Vitamin D is low β causing joint pains, bone aches, muscle weakness |
| How to take | WITH food that contains some oil or fat (paratha, egg, dal with oil) β Vitamin D does not absorb without fat |
| Expected benefit | Joint pains, muscle weakness and bone aches will improve in 4β6 weeks |
| What to know | Detail |
|---|---|
| Why you take it | Removes excess sugar through urine; protects heart and kidneys |
| How to take | WITH breakfast |
| Important side effects to know | You will pass more urine than usual β this is normal and expected |
| You MUST drink 2.5β3 litres of water daily | This medicine removes water from your body β if you do not drink enough, your BP will fall dangerously |
| Signs of too much water loss | Extreme thirst, dark yellow urine, dizziness, fainting β drink water immediately and rest |
| Genital hygiene | This medicine increases sugar in urine β clean the genital area properly after every toilet visit to prevent infection (itching/burning/discharge) |
| What to know | Detail |
|---|---|
| Why you take it | Three medicines in one tablet to control your sugar from three different angles |
| π΄ MOST IMPORTANT RULE | NEVER take this tablet on an empty stomach. Always eat a proper meal first |
| Glimepiride warning | This component forces your body to release insulin β if you skip a meal after taking this tablet, your sugar can fall dangerously low |
| Never skip meals | Breakfast, lunch and dinner are now medical necessities β not optional |
| What to know | Detail |
|---|---|
| Why you take it | Replaces iron and B12 to build up your blood |
| Why 9 AM specifically | Must be at least 4 hours AFTER your thyroid tablet, and at least 1 hour BEFORE your acid tablet (PPI) |
| Take with | A small glass of orange juice or lemon water β Vitamin C in the juice helps iron absorb better |
| Do NOT take with | Milk, tea, coffee, calcium tablets β these block iron absorption completely |
| Important reality | Because of your large fibroid causing blood loss every month, iron tablets alone may not be enough. You may need an iron injection (IV iron) β discuss with your doctor |
| What to know | Detail |
|---|---|
| Why you take it | Repairs nerves, reduces joint pains, fights fatigue, supports blood building |
| How to take | After eating lunch |
| Expected benefit | Nerve-related joint pains and tiredness will improve over 4β6 weeks |
| What to know | Detail |
|---|---|
| Why you take it | Controls heart rate and blood pressure |
| How to take | With food β never crush or chew (it is a sustained release tablet) |
| Important | This tablet hides the fast heartbeat that normally warns you when sugar is low β so you must check sugar regularly, especially if you feel sweaty or confused |
| What to know | Detail |
|---|---|
| Why you use it | Direct pain relief to the joint area without harming your stomach |
| How to use | Spray 2β3 times on the painful joint, rub gently. Wash hands after |
| This is the SAFEST pain relief for you | Use this instead of pain tablets whenever possible |
| What to know | Detail |
|---|---|
| Why you take it | Reduces stomach acid; prevents heartburn; improves digestion |
| How to take | 30 minutes BEFORE dinner β swallow whole, do not crush |
| About your current heartburn | Your chest burn and back burn happened because you stopped Pan 80 suddenly. This is called "rebound acidity" β your stomach made extra acid. Pan 40 will slowly settle this over 2 weeks |
| Aim | After 2β4 weeks, you should be on only ONE acid tablet (Nexom RD) β not two |
| What to know | Detail |
|---|---|
| Why you take it | Protects your heart and blood vessels from cholesterol damage |
| How to take | With or after dinner β works best at night |
| Good news | Your cholesterol numbers are all within normal range β this tablet is working well |
| What to know | Detail |
|---|---|
| Why you take it | Reduces joint inflammation |
| π΄ Critical rule | ALWAYS take with a full meal β NEVER on empty stomach |
| π΄ Sugar warning | This tablet will INCREASE your blood sugar significantly. Check your sugar more frequently while on this tablet |
| π΄ Must inform diabetologist | Your diabetes doctor must know you are on this steroid β it fights against your sugar tablets |
| Bone warning | Steroid weakens bones β ensure Vitamin D (Lumina) and calcium intake is adequate |
| Duration | Take for the MINIMUM time prescribed. Never increase dose on your own |
| What to know | Detail |
|---|---|
| Why you take it | Reduces nerve-related joint pains; helps sleep |
| How to take | At bedtime with water |
| Dizziness warning | This tablet can cause dizziness β sit at the edge of the bed for 60 seconds before lying down. If you wake up at night to use the toilet, sit up slowly first |
| π΄ Night sugar check | Because Glimepiride (in Gemersita IR) + this tablet together can cause low sugar at night β check blood sugar before sleeping. It must be above 120 mg/dL |
| Keep at bedside | Glucose tablets or 2 sugar cubes β every night, without fail |
| Sign | What You Feel |
|---|---|
| Sweating suddenly | Wet forehead, neck, back |
| Shaking hands | Trembling without reason |
| Sudden hunger | Feeling urgently hungry |
| Confusion | Cannot think clearly, feel strange |
| Blurred vision | Cannot see properly suddenly |
| Weakness suddenly worse | More than usual |
| Pale face | Family member notices you look pale/unwell |
STEP 1: Sit down immediately β do not stand
STEP 2: Take 15g of fast sugar RIGHT NOW:
β 3 glucose tablets OR
β 1 tablespoon sugar dissolved in water OR
β 150 mL (small glass) fruit juice OR
β 3β4 teaspoons honey
STEP 3: Wait 15 minutes
STEP 4: Check blood sugar if glucometer available
STEP 5: Eat a proper snack (biscuits, bread, banana)
STEP 6: If no improvement or unconscious β CALL EMERGENCY
| Food | How Often |
|---|---|
| Spinach, methi, palak, drumstick leaves | Daily |
| Pomegranate, dates (2β3), figs (2β3) | Daily |
| Jaggery (small amount) | Can be used instead of sugar |
| Cooked lentils (dal), rajma, chana | Every meal |
| Sesame seeds (til), flaxseeds | 1 tsp daily |
| Lean chicken/fish/eggs | 3β4 times/week |
| Beetroot, carrots | 4β5 times/week |
| Vitamin C with every iron-rich meal | Lemon squeezed on food, raw tomato, amla β increases iron absorption by 3Γ |
| Eat More | Eat Less / Avoid |
|---|---|
| Brown rice, jowar, bajra roti | White rice (large portions), maida |
| Vegetables (all non-starchy) | Potatoes, sweet potatoes (limit) |
| Whole lentils and legumes | Sugary drinks, juices, cold drinks |
| Curd (plain, unsweetened) | Sweets, mithai, biscuits, bread |
| Cucumber, tomato, leafy greens | Fried snacks, fast food |
| Small frequent meals | Large single meals |
| Food | Benefit |
|---|---|
| Sesame (til) chutney / ladoo | Calcium |
| Ragi (finger millet) roti | Highest calcium grain |
| Milk (1 glass daily, 4 hrs away from thyroid tablet) | Calcium |
| Walnuts, almonds (4β5 soaked daily) | Omega-3, bone health |
| Sunlight exposure 15β20 min daily | Natural Vitamin D |
| Food/Drink | Avoid With | Reason |
|---|---|---|
| Tea, coffee | Sederom (iron) | Tannins block iron absorption by 60% |
| Milk, dairy | Sederom, Thyroxine | Calcium blocks both |
| Soy products | Thyroxine | Blocks thyroid hormone absorption |
| High-fibre bran cereals | Thyroxine, iron | Both compete for absorption |
| Alcohol | All medications | Dangerous interactions |
| Time | Meal |
|---|---|
| 6:00 AM | Thyroxine tablet (alone) + warm water |
| 7:00 AM | 2 jowar/bajra rotis + egg bhurji with spinach + 1 small cup curd |
| 9:00 AM | Sederom tablet + 1 small glass orange juice / nimbu pani |
| 10:30 AM | Handful soaked almonds/walnuts + 1 small fruit (guava/apple) |
| 1:00 PM | 1 cup brown rice/2 rotis + dal + sabzi + salad with lemon |
| 4:00 PM | Roasted chana OR ragi biscuits + green tea (not with tablets) |
| 7:00 PM | 2 rotis + sabzi with leafy greens + 1 cup curd / raita |
| Bedtime | 1 glass warm milk (if sugar is in range) OR 2 biscuits |
| Activity | How |
|---|---|
| Walk gently | 15β20 minutes slow walk daily. Do NOT do strenuous exercise with Hb 7.6 β it strains your heart |
| Sunlight | 15β20 minutes morning sun (9β10 AM) on arms and legs daily β free Vitamin D |
| Hydration | 2.5β3 litres water daily β mandatory with Empagliflozin |
| Sleep | 7β8 hours every night. Use 2 pillows to raise your head (reduces nighttime acid reflux) |
| Stress management | Stress raises blood sugar. Practice slow breathing or prayer 10 minutes daily |
| Hygiene | Clean genital area after every toilet visit (Empagliflozin makes urine sugary β infection risk) |
| Avoid | Reason |
|---|---|
| β Skipping meals | Glimepiride causes dangerous sugar drop without food |
| β Fasting / religious fasts without medical advice | Very risky with current medications |
| β Self-medicating pain with over-the-counter painkillers (Combiflam, Ibuprofen, Diclofenac tablets) | Worsens bleeding, anaemia and kidneys |
| β Lifting heavy weights | Worsens umbilical hernia |
| β Straining at toilet (constipation) | Increases hernia size and risk |
| β Stopping any tablet without consulting doctor | Stopping thyroid tablet, sugar tablets or PPI abruptly causes dangerous rebound effects |
| β Getting up suddenly from bed/chair | Low BP + Pregabalin = fainting risk |
| What | How Often | Action If Abnormal |
|---|---|---|
| Blood Sugar (Glucometer) | Fasting every morning + Before bed every night | If fasting <70 or bedtime <120 β eat sugar and recheck |
| Blood Pressure | Once daily at same time | If <90/60 β sit down, drink water, call doctor |
| Weight | Once a week | Sudden weight gain (>1 kg/week) = fluid retention from steroid β call doctor |
| Urine colour | Daily | Dark yellow = not drinking enough water β increase fluids |
| Hernia lump | Daily | If lump becomes hard, painful, cannot be pushed in β go to emergency immediately |
| Period bleeding | Each cycle | If bleeding is very heavy (soaking >1 pad/hour) β go to hospital |
| Heartburn | Daily | Should improve with Pan 40 over 2 weeks; if worsening β contact doctor |
| Time | Target |
|---|---|
| Before breakfast (fasting) | 80β130 mg/dL |
| 2 hours after any meal | Below 180 mg/dL |
| Before bedtime | Above 120 mg/dL |
| HbA1c (3-monthly test) | Below 7.0% (currently 8.4% β improving) |
| Question | Answer |
|---|---|
| Why is surgery needed? | Your fibroid is 8.5 cm β very large. It is causing your heavy periods and severe low blood. No tablet can permanently cure a fibroid this size |
| When can surgery happen? | Only AFTER your blood level rises to at least 10 g/dL. This takes 6β8 weeks with proper iron treatment |
| What type of surgery? | Your gynaecologist will decide β either removing the fibroid alone (myomectomy) or the whole uterus (hysterectomy). Both are safe |
| Will it cure the anaemia? | YES β once the fibroid is removed, the heavy bleeding stops, and your blood level will recover fully |
| Fear of surgery | Your diabetes and low blood make surgery slightly more complex β but with proper preparation (controlled sugar, good blood level), it is very safe |
| Question | Answer |
|---|---|
| Why is repair needed? | 4 cm hernia with a large fibroid pushing from inside β risk of bowel getting trapped (strangulation) is real |
| Can both surgeries be done together? | YES β gynaecologist and general surgeon can plan joint surgery. One anaesthesia, one recovery |
| Emergency signs | If hernia becomes suddenly painful, hard, red, you cannot push it back in β go to emergency THAT DAY |
| Question | Answer |
|---|---|
| Why IV and not just tablets? | Your stomach acid tablets (PPIs) are blocking iron tablet absorption. IV iron bypasses the stomach completely and raises blood level faster |
| Is it safe? | Yes β done in a clinic/hospital over 3β4 hours. Highly effective |
| How fast does it work? | Hb starts rising in 1β2 weeks; full effect in 4 weeks |
| π¨ Emergency Sign | Possible Cause |
|---|---|
| Sudden severe dizziness / fainting | Low BP + low sugar + anaemia |
| Shaking, sweating, confusion after skipping meal | Hypoglycaemia (low sugar) |
| Hernia lump becomes hard, painful, immovable | Strangulation β surgical emergency |
| Very heavy menstrual bleeding (soaking pad within 1 hour) | Fibroid bleeding |
| Chest pain / palpitations | Severe anaemia straining heart |
| High fever + burning urine | Urinary infection (Empagliflozin risk) |
| Sudden shortness of breath | Severe anaemia / cardiac stress |
| Vomiting + abdominal pain + no bowel movement | Bowel obstruction from hernia |
| Blood sugar >300 mg/dL with nausea/vomiting | Possible DKA β hospital immediately |
| Blood sugar <50 mg/dL not responding to sugar intake | Severe hypoglycaemia β emergency |
| When | What For | Doctor |
|---|---|---|
| Within 1 week | IV iron infusion decision; fibroid management | Gynaecologist |
| Within 1 week | Inform about Deflazacort prescription; glucose monitoring plan | Diabetologist |
| Within 1 week | ECG before continuing Nexom RD (Domperidone + Metoprolol) | General Physician / Cardiologist |
| 2 weeks | Recheck Hb + BP; iron absorption review; step down Pan 40 | General Physician |
| 4 weeks | Repeat CBC, FBS, PPBS, BP; evaluate Deflazacort effect on sugar | Diabetologist |
| 6 weeks | Repeat TSH (new medicines may affect thyroid control) | General Physician |
| 8β10 weeks | Pre-operative evaluation (once Hb >10) | Anaesthesiologist + Surgeon |
| 3 months | HbA1c, Vitamin D level, B12 level, serum ferritin | All doctors |
| Ongoing | SPEP, HBsAg, Anti-CCP, ANA β pending tests | Lab |
| How Family Can Help | Why It Matters |
|---|---|
| Remind her to take Thyroxine alone at 6 AM | Easy to forget; critical not to miss |
| Ensure she eats a proper meal before Gemersita IR | Prevents dangerous low sugar episodes |
| Keep glucose tablets at home and in her purse | Emergency hypoglycaemia management |
| Watch for signs of low sugar (sweating, confusion, shaking) | Beta-blocker hides her fast heartbeat warning sign |
| Accompany her to hospital visits | Complex multi-doctor management needs support |
| Encourage adequate water intake daily | Empagliflozin dehydration risk |
| Watch the hernia lump daily | Strangulation is an emergency β family can detect it |
βββββββββββββββββββββββββββββββββββββββββββββββββββββββββββ
β MRS. TAHNIYATH FATIMA β DAILY MEDICINES β
ββββββββββββ¬βββββββββββββββββββββββββββββββββββββββββββββββ€
β 6:00 AM β Thyroxine 88 mcg β ALONE, empty stomach β
β 7:00 AM β Lumina + Empagliflozin 25 mg + Gemersita IR β
β β (WITH FULL BREAKFAST β never skip meal) β
β 9:00 AM β Sederom β with nimbu pani/orange juice β
β 1:00 PM β Neurofol LC + Prolomet XL 25 (after lunch) β
β 6:30 PM β Nexom RD (30 min before dinner) β
β 7:00 PM β Rosuvastatin + Deflazacort (WITH dinner) β
β 10:00 PM β Pregadoxt 75 β CHECK SUGAR FIRST β
β β Must be >120 mg/dL before sleeping β
ββββββββββββ΄βββββββββββββββββββββββββββββββββββββββββββββββ€
β EMERGENCY LOW SUGAR: 3 glucose tablets OR 1 tbsp sugar β
β EMERGENCY HERNIA: Hard painful lump β go to hospital β
β DAILY WATER TARGET: 2.5β3 litres minimum β
β NEVER SKIP MEALS while on Gemersita IR β
βββββββββββββββββββββββββββββββββββββββββββββββββββββββββββ
π¬ "Your body is fighting hard. With the right medicines taken at the right time, the right food, enough water, and regular doctor visits β you will feel significantly better. The fibroid is the root cause of most of your suffering. Once it is treated, your blood will recover, your energy will return, and your quality of life will improve greatly."
After the check up medication prescribed are lupiheme,mifepristone 25mg,limcee tab hefinac
| Parameter | Value | Status |
|---|---|---|
| Weight | 74 kg | Noted |
| BP | 100/70 mmHg | π‘ Low-normal (improved from <95!) |
| LMP | Day 5 (currently menstruating) | Active period |
| HbA1c (noted by doctor) | 8.4% | π΄ Uncontrolled |
| Hb | 7.6 g/dL | π΄ Severe anaemia |
| Finding | Previous USG (7 Apr) | Current USG (14 Apr) | Significance |
|---|---|---|---|
| Liver | Normal echotexture | Increased echotexture β Grade I Fatty Liver | π΄ NEW finding |
| Fibroid size | 85 Γ 75 mm (subserosal, LUS) | 66 Γ 51 mm (anterior wall, displacing endometrium) | Different scan/view β same fibroid |
| Uterus size | 90 Γ 45 Γ 50 mm | 112 Γ 69 mm β Bulky | Larger measurement confirms bulky uterus |
| Endometrial thickness | 7 mm | 9.6 mm | π΄ Increased β needs attention |
| Hernia | 40 mm umbilical | 3β4 cm supraumbilical with omentum as content | Confirmed; omentum is inside hernia sac |
| Kidneys | 98Γ48mm / 96Γ46mm | 101Γ43mm / 103Γ45mm | Mildly enlarged β monitor |
| Lymph nodes | No para-aortic LAD | No lymphadenopathy | β Reassuring |
| Peritoneum | No free fluid | No free fluid, no pleural effusion | β Normal |
| Grade | Fat Content | Echotexture |
|---|---|---|
| Grade I (this patient) | 5β33% of liver cells contain fat | Mildly increased |
| Grade II | 33β66% | Moderately increased |
| Grade III | >66% | Severely increased |
16 years of Type 2 Diabetes
β
Insulin resistance β excess glucose in blood
β
Liver converts excess glucose β triglycerides
β
Fat deposits inside liver cells
β
Grade I Fatty Liver (NAFLD)
| Action | Detail |
|---|---|
| Best treatment: Tight glucose control | Bringing HbA1c to <7% reverses Grade I fatty liver |
| Empagliflozin (already prescribed) | SGLT2 inhibitors are proven to reduce liver fat β excellent choice |
| Weight reduction | Even 5β7% body weight loss reverses hepatic steatosis |
| Avoid alcohol (if any) | Absolutely contraindicated |
| Stop/minimise Deflazacort | Steroids worsen fatty liver β shortest possible course |
| Dietary fat modification | Reduce saturated fats (fried food, ghee excess); increase omega-3 (fish, walnuts) |
| Repeat USG in 3β6 months | Monitor progression or reversal |
| Patient Status | Normal ET | This Patient |
|---|---|---|
| Premenopausal Day 5 (menstruating) | Should be <5 mm (shedding phase) | 9.6 mm β THICK for Day 5 |
| Premenopausal (proliferative mid-cycle) | 8β10 mm | Would be normal mid-cycle |
| Postmenopausal | <5 mm mandatory | β |
β οΈ Endometrial biopsy or hysteroscopy is now strongly recommended to evaluate the thick endometrium and polyp, especially in a diabetic perimenopausal woman where endometrial cancer risk is elevated.
| Kidney | Previous (7 Apr) | Current (14 Apr) |
|---|---|---|
| Right | 98 Γ 48 mm | 101 Γ 43 mm |
| Left | 96 Γ 46 mm | 103 Γ 45 mm |
| What to know | Detail |
|---|---|
| What is liposomal iron? | Iron encapsulated in a lipid (fat) shell β absorbed DIRECTLY through intestinal cells WITHOUT needing gastric acid |
| Why this is a game changer | Previous Sederom (ferric diphosphate) needed gastric acid β was being blocked by Pantoprazole/Esomeprazole. Lupiheme BYPASSES this blockage completely |
| Absorption rate | 3β5Γ better than conventional iron salts |
| Side effects | Far less GI side effects (no constipation, nausea, dark stool) compared to ferrous sulphate |
| Effect on HbA1c test | Being liposomal β less interference with red cell measurements |
| What to know | Detail |
|---|---|
| How it works | Blocks progesterone receptors in the uterus and fibroid. Since fibroids are progesterone-dependent for growth, blocking progesterone: stops fibroid from growing, can shrink it by 26β74%, and dramatically reduces menstrual bleeding |
| Expected benefits | Reduced heavy bleeding within 1β2 cycles; fibroid volume reduction over 3β6 months |
| Why 25 mg dose | Low-dose mifepristone (10β25 mg) is proven effective for fibroids with fewer side effects than high-dose |
| Duration | Typically 3β6 months β then reassess for surgery |
| Goal | Shrink fibroid + stop/reduce heavy bleeding β allow Hb to rise before surgery |
| Interaction | Risk | Detail |
|---|---|---|
| Mifepristone + Deflazacort (steroid) | π΄ Important | Mifepristone is an anti-glucocorticoid at higher doses β at 25 mg, this effect is minimal but worth monitoring. If patient feels steroid withdrawal symptoms (extreme fatigue, low BP) β inform doctor |
| Mifepristone + Empagliflozin | π’ Safe | No significant interaction |
| Mifepristone + Thyroxine | π’ Safe | No significant interaction |
| Mifepristone + Gemersita IR | π’ Safe | No significant interaction |
β οΈ Because mifepristone can cause endometrial changes (simple hyperplasia without atypia in some studies), the 9.6 mm endometrial thickness MUST be evaluated BEFORE or early during mifepristone treatment. Hysteroscopy or endometrial biopsy is recommended.
| What to know | Detail |
|---|---|
| Why prescribed | Vitamin C converts ferric iron (FeΒ³βΊ) to ferrous iron (FeΒ²βΊ) β enhances iron absorption by up to 3Γ |
| Specifically helps Lupiheme | Even though liposomal iron absorbs independently, Vitamin C provides antioxidant support and immune benefit |
| Additional benefits | Antioxidant β reduces oxidative stress in diabetes; supports collagen formation (wound healing for upcoming surgery); immune support |
| How to take | Chew or dissolve in water β take WITH Lupiheme for maximum iron absorption benefit |
| Safe | No significant interactions with any of her current medications |
| What to know | Detail |
|---|---|
| Class | NSAID β same family as Diclofenac, Ibuprofen |
| Why prescribed | Pain relief for joint pains |
| Interaction | Risk | Severity |
|---|---|---|
| Hefinac + Anaemia (Hb 7.6) + Fibroid bleeding | NSAIDs can worsen menstrual bleeding AND cause GI bleeding β double bleeding risk | π΄ Critical |
| Hefinac + Empagliflozin | NSAID + SGLT2i = kidney stress β AKI risk | π΄ High |
| Hefinac + Ibuprofen (Mega Flexon) | TWO oral NSAIDs simultaneously = dramatically increased GI bleed risk | π΄ Critical β avoid combination |
| Hefinac + Deflazacort | NSAID + steroid = 15Γ higher GI ulcer/bleed risk | π΄ Critical |
| Hefinac + Mifepristone | Both affect uterine prostaglandins β may alter mifepristone's mechanism | π‘ Moderate |
| # | Drug | Composition | Purpose | Status |
|---|---|---|---|---|
| 1 | Thyroxine 88 mcg | Levothyroxine | Hypothyroidism | β Continue |
| 2 | Lumina | Vitamin D3 | Bone/muscle | β Continue |
| 3 | Prolomet XL 25 | Metoprolol | Heart/BP | β Continue |
| 4 | Pan 40 | Pantoprazole 40 mg | Acid (step-down) | π‘ Phase out β Nexom RD only |
| 5 | Rosuvastatin 10 mg | Rosuvastatin | Cholesterol | β Continue |
| 6 | Lupiheme (NEW) | Liposomal Iron + Folic Acid | Anaemia | β Excellent choice |
| 7 | Empagliflozin 25 mg | SGLT2i | T2DM | β Also helps fatty liver |
| 8 | Gemersita IR | Sitagliptin + Metformin + Glimepiride | T2DM | β Continue with meal rules |
| 9 | Mifepristone 25 mg (NEW) | Antiprogestin | Fibroid shrinkage | β Appropriate |
| 10 | Limcee 500 mg (NEW) | Vitamin C | Iron absorption | β Beneficial |
| 11 | Hefinac (NEW) | Aceclofenac 100 mg | Joint pain | β οΈ Do NOT combine with Mega Flexon ibuprofen |
| 12 | Nexom RD | Esomeprazole + Domperidone | Acid/nausea | β Continue |
| 13 | Deflawok 6 mg BD | Deflazacort | Joints (ortho) | π΄ Worsens sugar + fatty liver |
| 14 | Mega Flexon BD | Paracetamol + Ibuprofen + Chlorzoxazone | Pain (ortho) | π΄ Stop ibuprofen β Hefinac replaces it |
| 15 | Pregadoxt 75 | Pregabalin 75 mg | Neuropathic pain | π‘ Continue with caution |
| 16 | Neurofol LC | L-Carnitine + B12 + Folic Acid | Nerve support | β Continue |
| 17 | Diclogesic Maxx Spray | Diclofenac topical | Joint pain | β Preferred β use this |
| 18 | Sederom | Ferric Diphosphate + B12 + Vit C | (being replaced by Lupiheme) | π‘ Can be stopped now Lupiheme started |
π
6:00 AM β Empty stomach:
β Thyroxine 88 mcg (ALONE β plain water only)
π³ 7:00 AM β WITH full breakfast:
β Lumina (Vitamin D3) β WITH food
β Empagliflozin 25 mg β WITH breakfast
β Gemersita IR β WITH breakfast (NEVER skip meal)
β Mifepristone 25 mg β WITH food (reduces nausea)
βοΈ 8:00β9:00 AM β 2 hours after Thyroxine:
β Lupiheme (Liposomal Iron) β can take with or without food
β Limcee 500 mg (Vitamin C) β CHEW with Lupiheme
π 1:00 PM β After lunch:
β Neurofol LC (L-Carnitine + B12 + Folic Acid)
β Prolomet XL 25 β WITH food
β Diclogesic Maxx Spray β apply to painful joints
π 6:30 PM β 30 min before dinner:
β Nexom RD (Esomeprazole + Domperidone SR)
β Stop Pan 40 now β Nexom RD is sufficient as single PPI
π 7:00 PM β WITH full dinner:
β Rosuvastatin 10 mg
β Deflazacort 6 mg (if continued β STRICTLY with food)
β Hefinac 100 mg (if needed for pain β WITH food, covered by Nexom RD)
β DO NOT take Mega Flexon ibuprofen on days Hefinac is taken
π 9:30β10:00 PM β Bedtime:
β Pregadoxt 75 (Pregabalin)
β Check blood sugar before sleeping (must be >120 mg/dL)
β Glucose tablets on bedside table
"Your liver has started accumulating some fat β Grade 1, which is the mildest stage. This is completely reversible. Think of it like a small warning light in your body. The main cause is your diabetes, and the best treatment is bringing your sugar under control."
| β Eat More | β Reduce/Avoid |
|---|---|
| Green leafy vegetables | Fried foods (samosas, pakodas, chips) |
| Oats, barley | Excess ghee/butter/coconut oil |
| Walnuts, flaxseeds (omega-3) | Sweetened drinks, packaged juices |
| Garlic, turmeric (anti-inflammatory) | Maida-based foods (bread, biscuits, naan) |
| Coffee (1β2 cups unsweetened) β shown to protect liver | Red meat in excess |
| Fruits (limited β whole, not juiced) | Alcohol β absolutely zero |
| Previous Unknown | Now Confirmed |
|---|---|
| Cause of polymenorrhagia | Anterior wall fibroid 66Γ51mm displacing endometrium + small endometrial polyp |
| Why iron treatment failing | Fibroid causing ongoing heavy blood loss every month outpacing iron supplements |
| New fatty liver finding | Grade I NAFLD from 16-year uncontrolled T2DM |
| Endometrial concern | 9.6 mm on Day 5 β needs biopsy/hysteroscopy before mifepristone course |
| Surgical plan confirmed | Tubal ligation done β fertility not a concern β hysterectomy is best option |
| Hernia content | Omentum (not bowel) β slightly lower emergency risk but still needs repair |
| Priority | Action | When |
|---|---|---|
| π΄ 1 | Stop Mega Flexon Ibuprofen β Hefinac (aceclofenac) replaces the NSAID component. Do NOT take both | Immediately |
| π΄ 2 | Stop Sederom β Lupiheme replaces it (better absorbed, no PPI conflict) | Immediately |
| π΄ 3 | Stop Pan 40 β Nexom RD alone is sufficient now | Immediately |
| π΄ 4 | Endometrial biopsy / Hysteroscopy β 9.6mm on Day 5 + small polyp seen β before or early during mifepristone treatment | Within 1β2 weeks |
| π΄ 5 | Inform diabetologist about Grade I fatty liver + Deflazacort prescription | Next visit |
| π‘ 6 | Mifepristone 25 mg β take as prescribed; expect reduction in bleeding within 1β2 cycles | Start now |
| π‘ 7 | Repeat Hb after 4 weeks β Lupiheme should show measurable improvement | 4 weeks |
| π‘ 8 | Repeat USG liver in 3 months β monitor fatty liver regression | 3 months |
| π‘ 9 | Microalbuminuria + eGFR β kidneys mildly enlarged, 16-year DM | Within 2 weeks |
| β 10 | Limcee + Lupiheme + Neurofol LC + Mifepristone β all appropriate, continue | Now |
Week 1β2:
β Lupiheme starts absorbing iron effectively (bypasses PPI blockage)
β Mifepristone begins reducing fibroid-driven blood loss
β Heartburn/chest burn settles with Pan 40 step-down + Nexom RD
Week 4β6:
β Hb expected to rise from 7.6 to 9.0β9.5 g/dL
β Heavy menstrual bleeding noticeably reduced
β Weakness and dizziness improving
β Vitamin D correction improving joint pains
Month 2β3:
β Hb approaching 10+ g/dL
β Fibroid may show 20β40% volume reduction on mifepristone
β BP stabilising as anaemia corrects
β Fatty liver: beginning to improve with better glucose control
Month 3β4 (Pre-operative target):
β Hb >10 g/dL β
β HbA1c approaching 7.0β7.5% β
β BP stable >100 mmHg β
β READY for combined fibroid surgery + hernia repair
β The gynaecologist's prescription is clinically sound and well-targeted:
- Lupiheme solves the PPI-iron absorption conflict
- Mifepristone 25 mg directly addresses the root cause (fibroid + heavy bleeding)
- Limcee supports iron absorption
- Hefinac manages joint pain (replaces oral ibuprofen β not in addition to it)
β οΈ The only remaining concern is the 9.6 mm endometrial thickness on Day 5 β this needs hysteroscopy/biopsy before completing the mifepristone course, as both the fibroid and mifepristone itself can cause endometrial changes that must be monitored in a diabetic perimenopausal woman.
As per pharm d same pt